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ABSTRACT  
 
Peavy, Katherine Michelle, Ph.D., May 2009,    Psychology 
 
Crossing the threshold: What motivates individuals who are actively abusing substances 
to enter treatment? 
 
Chairperson:  Bryan N. Cochran, Ph.D. 
 
  Although there is an abundance of research in the area of substance abuse, much of it 
samples people who are already enrolled in treatment. The treatment seeking population 
may differ from people who are actively using substances. One aim of this study is to 
describe a sample of individuals who have not sought out treatment, but still actively use 
substances. Specifically, the investigators assessed 51 county detention facility inmates 
recently arrested on drug- or alcohol-related charges, examining the factors that both 
inhibit and promote treatment seeking. We hypothesized that motivation levels for 
seeking treatment would differ based on several factors: family and social distress, 
psychological distress, medical problems, severity of drug and alcohol abuse, and 
primary drug of abuse. Results demonstrated that high levels of psychological distress, as 
well as distress in one’s family/social life, were related to higher levels of motivation for 
change. We also examined perceived barriers to treatment, which revealed that 
participants endorsed barriers related to motivation (lack of) and self-perception of drug 
use. The results of this study have implications for developing brief interventions that 
could help facilitate the entry of moderately motivated substance users into treatment 
settings. Shortening the gap between a person’s introduction to substance abuse and 
entrance into treatment could prevent an escalation of substance use that would incur 
greater consequences, both to the individual user and to society.  
iii 
 
TABLE OF CONTENTS 
 Page 
Introduction ……………………………………………………………………………….1
 Etiology of addiction…..…...……...………………………………………………2 
Substance use and the legal system…………..…………………………………...5 
Substance abuse treatment………………………………………………………...9 
 Motivation for treatment…………………………….…………………………...17 
 Hypotheses……………………………………………………………………….29 
Methods……………………………………………………………………….…….……33 
Participants.………………………………………………………………………33 
Setting….…………………………………………………………...……………33 
Procedures………………………………………………………………………..34 
Measures……………………………………………………………………........35 
Analyses…………………………………………………………………….........43 
Results……………………………………………………………………………………47 
Demographic variables..…..…………………………………………………......47 
Psychosocial stability……….……………………………………………............47 
Motivation for treatment……………………………………………………........49 
Exploratory analyses: Barriers to treatment…………………………......………54 
Exploratory analyses: Etiology of addiction……………………………………..55 
Discussion……………………………………………………………………..…………57 
Motivation: Summary and interpretations……………………………………….57 
Treatment choice………………………………………………............................61 
iv 
 
Barriers to treatment……………………………………………………………..64 
Future directions for researchers and clinicians…………………………………65 
Study limitations and strengths…………………………………………………..69 
References …………………………………………………………………………….…71 
Appendix A: Etiology of addiction questionnaire…………………………………….....90 
Appendix B: Treatment choice rationales………………………………………………..97 
Tables  
1. Sample characteristics………………………………………………………...99 
2. Psychosocial stability………………….……………………………………..100 
3. Means and standard deviations of BSI subscale scores for current and 
normative samples……………………………………………………………...101 
4. t-test values for comparison between the current sample and normative samples
 for BSI subscales………………………………………………………………..102 
5. Correlations among predictor and outcome variables……………………….103 
6. Linear regression model predicting readiness to change…………………….104 
7. Comparison of BSI scores for stage of change groups………………………105 
8. Percentage endorsing items on the Barriers Questionnaire and corresponding 
factors…………………………………………………………………………...107 
   
 
1 
 
Introduction 
 Many individuals who struggle with substance abuse disorders have difficult 
lives fraught with financial, legal, and medical problems. The costs of substance abuse to 
greater society, however, occur on a much larger scale, incurring detrimental effects on 
economic and legal institutions, as well as the public’s health. Measured in actual dollar 
amounts, drug-related crime costs comprise over half of the entire economic costs of drug 
abuse in the United States (Office of National Drug Control Policy; ONDCP, 2004). 
While substance use is clearly related to societal problems, a silver lining comes in the 
form of research on the effectiveness of many types of treatment for this population 
(Hubbard, Craddock, Flynn, Anderson, & Etheridge, 1997). Because treatment works, 
and has been shown to decrease costs to society (Ettner et al., 2006), it seems imperative 
to find ways of directing the population of substance users into treatment settings. 
Therefore, important aspects about substance abuse behavior merit examination. One of 
these aspects is etiology of a person’s addiction. That is, how are people influenced to 
experiment with substances? Perhaps more importantly, investigating why people 
progress from initial substance use to problematic substance abuse and dependence may 
help in developing prevention strategies. Another important aspect to consider is what 
motivates active substance abusers to seek treatment. Research in this area has 
implications for developing intervention strategies for substance abusing individuals. 
Because much of the research conducted with substance abusing samples utilizes 
participants who are already in treatment, we believe it is important to examine 
motivational factors in a non-treatment seeking sample.   
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E tiology of addiction 
The etiology of substance use disorders is undoubtedly a combination of 
biological, psychological, and social factors. However, the degree to which each of these 
factors contributes to the development of substance use disorders is a subject of 
considerable debate among theorists and researchers. Furthermore, this is obviously an 
area in which researchers show a great deal of interest. For example, the literature 
overwhelmingly supports the idea that family factors play a role in adolescent substance 
use. The family environment may serve as a protective factor in delaying or reducing in 
frequency of substance use (Kumpfer & Alvarado, 2003).  
A perusal of the literature on family therapy for substance abuse will reveal 
several references to the concept of substance abuse as a “family disease” (e.g., Kumpfer, 
Alvarado, & Whiteside, 2003; Whittinghill, 2002). This perspective is one heavily 
influenced by family systems theory. From this viewpoint, substance abuse is believed to 
develop from, and is maintained by, a dysfunctional family unit. For example, family 
members may enable the substance abuser to keep using in order to reduce conflict or 
restlessness (Saatcioglu, Erim, & Cakmak, 2006). Family may also serve as a risk factor 
for predicting problematic drug use; for example, in the instance of low attachment 
between parent and child (Barnes, Barnes, & Patton, 2005). Other risk factors that predict 
adolescent substance abuse include sexual abuse, non-sexual violence (Clark, Lesnick, & 
Hegedus, 1997; Lipschitz, Grilo, Fehon, McGlashan, & Southwick, 2000), and peer 
substance use (Bray, Adams, Getz, & McQueen, 2003). It should be noted that the 
literature on predictors of substance abuse focuses primarily on adolescent populations. 
Examining adolescent substance abuse is important because the younger a person is when 
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he or she begins to use substances, the more likely he or she is to later develop a 
substance use disorder (Shedler & Block, 1990).  
The aforementioned variables that predict the development of substance use 
would be best described as environmental, in terms of their locus of influence. Other, 
more detailed models of the development of addiction have been proposed by researchers 
spanning the discipline, typically utilizing the biopsychosocial model as a foundation.  
For example, researchers have discussed the importance of genetic influences on 
substance abuse (Crabbe, 2002; Wahlsten, 1999). Lende and Smith (2002) also talk about 
a biological mechanism (the mesolimbic dopamine system) as a contributor to the 
development of substance abuse. They describe the etiology of addiction through an 
evolutionary framework, viewing some substance use as an adaptive, short-term life 
strategy. The authors argue that our dopaminergic systems have not developed 
appropriate regulation to detect, and correct for, the maladaptive behavior of excess 
substance use. In other words, the human body is evolutionarily ill equipped to contend 
with the abundance of available psychoactive substances that are now available in our 
environments. The authors contend that the lack of self-limiting environment is especially 
harmful for individuals who have more sensitive dopamine systems (due to heritability).  
Although researchers generally accept that genes contribute to part of the equation 
of explaining human behavior, other etiological models that also include the 
psychological and social factors provide a more complete picture of the development of 
substance use problems. For example, a model intended to explain the development of 
alcohol abuse exclusively is the Alcohol Expectancy Process (Goldman, 1999). 
According to this model, it is thought that early learning experiences influence 
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subsequent drinking decisions. Specifically, information from these alcohol-related 
experiences (and anticipated reinforcement) is thought to be stored in memory, later 
serving to influence future drinking-based decisions. Evidence in support of this model 
comes in the form of studies comparing heavy and light drinkers on their expectations 
(Rather, Goldman, Roehrich, & Brannick, 1992). As alcohol expectancy theory would 
indicate, heavier drinkers associate drinking with arousal and positive expectations, 
whereas lighter drinkers associate alcohol with its sedating effects.  This model also 
encompasses social factors. That is, vicarious learning or modeling are highlighted as 
evidence that alcohol expectancies appear in children before they begin drinking 
(Bauman & Bryan, 1980; Dunn & Goldman, 1996).  
A slightly different spin on the alcohol expectancy theory is provided by 
Newcomb and Earleywine (1996), who discuss the importance of intrapersonal 
contributors to the etiology of addiction. The authors implicate expectancies (cognitions) 
as causal factors in drug use, but also focus on other intrapersonal factors. For example, 
the personality traits that fall under the general heading of “behavioral undercontrol” 
have been linked to increased substance use behavior (Sher, Walitzer, Wood, & 
Brent,1991). Affect is another intrapersonal factor that has been shown to be related to 
substance use. Specifically, depression and negative feelings towards the self have been 
examined as variables that may be “medicated” by the use of substances (Kaplan, 1987).  
Ultimately, most researchers agree that substance use disorders are likely to arise 
from a complex interplay between a person’s biology, the environment, and intrapersonal 
or psychological variables. What these models and corresponding studies are missing, 
however, are detailed accounts of why the individual user believes he or she developed 
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substance difficulties. It is possible that one’s individual perception is an important aspect 
of understanding the etiology of substance use disorders. Such individual accounts could 
be important in determining which etiological factors are more salient for certain groups 
of individuals. While we believe it is important to consider how a person initially became 
addicted to substances, this consideration does not directly ameliorate the problems and 
societal costs associated with drug abuse. 
Substance use and the legal system 
Criminal activity associated with substance abuse is certainly one of the primary 
concerns in terms of social problems, given that its costs are so far reaching. On the 
smallest scale, drug-related criminal acts have an effect on the victim. The costs of such 
effects can be either measurable (such as property damage or loss) or immeasurable 
(“intangible costs” such as pain or suffering). Ironically, research indicates that chronic 
drug users are not only likely to be perpetrators of drug-related crimes, but also are more 
likely than non-drug users to be victims of crime themselves (French, McCollister, 
Alexandre, Chitwood, & McCoy, 2004). These findings indicate that the relationship 
between drug use and crime is circular, affecting the substance using population in 
multiple ways.  
Other costs of drug-related crime include related law enforcement and 
correctional expenditures. National statistics show that these costs add up quickly and 
sum to a staggering amount. Specifically, an estimated $107.8 billion was spent in 2002 
on drug-related crime in the United States (ONDCP, 2004). This figure is almost 60% of 
the total economic cost of drug abuse in this country, which includes health care costs 
and productivity losses. Overburdened correctional facilities receive a notable impact of 
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drug-related costs. Incarceration of inmates charged with drug-related crimes was 
estimated to total $39 billion in 2002 (ONDCP, 2004). Whether on an individual or 
communal basis, drug-related crime is clearly problematic on a number of levels. 
While the connection between substance abuse and crime is a robust and reliable 
one, the nature of this relationship has been construed in different ways by researchers. 
For example, Goldstein (1985) postulated that criminal activity is a result of drug use and 
its lifestyle. Implicit within this model is that the arrow of causality goes from drug use to 
criminal activity. Evidence for this model can be found by looking at statistics indicating 
that drugs are frequently implicated in crime. That is, research shows that those who are 
arrested for crimes often test positive for recent drug use. Data from the Arrestee Drug 
Abuse Monitoring (ADAM) Program indicated that the median percentage of male 
arrestees that tested positive for illicit drugs was 64.2 (National Institute of Justice, 2003). 
This percentage is 62.5 for female arrestees. Other data collected by U.S. Bureau of the 
Census had similar findings, corroborating the high rate drug use prior to arrests 
(Mumola, 1999). Specifically, a U.S. Bureau of the Census study involved the 
administration of surveys to prison inmates, asking whether they were under the 
influence of drugs at the time of the crime. Nearly 33% of state prison inmates and 22.4% 
of federal prison inmates endorsed being under the influence of drugs while committing 
their offenses. Other data in support of the idea that drug use is a causal factor for 
criminal activity is evidence that people who commit crimes often do so in order to 
support their drug habits. Convicted jail inmates surveyed in 2002 reported that 16% had 
committed their offense to obtain money to buy drugs (Karberg & James, 2005).  
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On the surface, these studies may suggest that the causal link between drugs and 
crime may be unidirectional. But other compelling evidence exists showing that crime 
may have a predictive relationship in terms of illegal drug use. The relationships between 
legal and illegal drug use, violence, and victimization are exemplified by Weiner, 
Sussman, Sun, and Dent (2005). These researchers conducted a 5-year prospective study 
with students attending continuation high schools; such institutions serve individuals who 
have transferred out of the regular high school system. They found that illegal drug use at 
baseline predicted both perpetration of violence and experiencing victimization at the 5-
year follow-up. Furthermore, this study tested whether the pharmacological effects of the 
drugs mediated this relationship. To do this, the investigators created a 
“psychopharmacological” index made up of questions regarding how often participants 
had experienced consequences such as injury, committing a crime, or fighting while 
under the influence of drugs or alcohol. The researchers found that this index mediated 
the relationship between drug use and violence and victimization, such that the 
relationship between drug use and violence was no longer significant when the 
psychopharmacological index was added into the model. This was also the case for the 
relationship between drug use and victimization. The authors concluded that the 
psychopharmacological effects of drug use (i.e., irritability from withdrawal) lead to 
violent behavior. Other psychopharmacological effects (i.e., decreased vigilance) may 
lead to victimization.   
While the abovementioned results may suggest that drug use precedes crime, 
other researchers have suggested different interpretations of the correlation. Chaiken and 
Chaiken (1990), for example, proposed that the arrow of causality points in the opposite 
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direction. That is, involvement in a criminal lifestyle may predict experimentation in drug 
use. One study substantiating this idea was carried out by Newcomb, Galaif, and 
Carmona (2001), who found that legal problems (such as theft charges and driving under 
the influence arrests) predicted later polydrug problems in a longitudinal study. 
Nonetheless, this same study found that drug problems were also a predictor of later 
criminal behavior, implying a bidirectional relationship.  
In terms of defining the relationship between substance use and crime, the most 
salient explanations in the literature are ones that do not attempt to simplify it, and 
instead speak to its complex nature. This consideration is brought forward by many 
researchers, indicating that other variables may affect both crime and drug use, and that 
the pathway from one to the other is complicated by other factors still being fleshed out. 
For example, Keene (2005) conducted a study showing a relationship between drug use 
and multiple types of crime; further analyses indicated that social and psychological 
problems mediate this relationship, such that these types of problems affect both drug use 
and crime. This research highlights the idea that there could be underlying factors 
affecting both drug use and criminal activity. Poverty has been described as one of those 
factors. Ford and Beveridge (2006) found that “neighborhood disadvantage” was 
associated with increases in the crimes of burglary and assault; high rates of drug use 
were only associated with crimes of burglary. Here, a relationship between poverty, 
crime, and drug use is exemplified, but only for a specific type of crime. Zhang (1997) 
showed that an increase in welfare payments is related to a decrease in property crime, 
indicating that financial strain may drive crime. Zhang did not discuss drug use in his 
analysis directly; instead, he implied that crimes were being committed because of an 
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actual need for financial resources. Following this line of reasoning was Hunt (1991), who 
put forward the idea that the likelihood of a particular substance user engaging in criminal 
activity may depend on his or her socioeconomic status. In other words, people who cannot 
afford a substance relative to their income are more likely to engage in criminal behavior. 
Although a well-studied area, there still appears to be little consensus about the exact 
nature of the relationship between substance use and crime. 
Finally, no distinction has been made thus far between illicit drugs and alcohol, in 
terms of their respective relationships to crime. Because simple possession or use of an 
illegal drug is inherently against the law, it might make sense to assume that illicit drug 
use is associated with more crime. Indeed, one study found that high school students’ use 
of drugs legal for adults (i.e., alcohol and cigarettes) did not predict later violence or 
victimization, whereas as the use of illegal drugs did (Weiner et al., 2005). However, 
other researchers have found an unsettling association between alcohol and violent crime, 
such that alcohol is more strongly correlated with violent crime than cocaine (Martin, 
Maxwell, White, & Zhang, 2005). While all illicit drug use is criminal by definition, the 
type of drug used may be related to the type of crime committed, further complicating the 
relationship between substance use and crime. Regardless of how these two variables are 
related, drug use and crime are inextricably linked, and public policies that address one 
but not the other seem destined to fail. 
Substance abuse treatment 
Because the relationship between drug use and crime is uncertain, the way we as a 
society should handle both of these behaviors may also seem unclear. Should the crime 
be punished in order to deter future crime and associated drug use? Or, should the drug 
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problem be treated in order to reduce drug use and, therefore, associated criminal 
activity? These are empirical questions to which an almost resounding consensus 
emerges in the data: treatment works both to reduce drug use (e.g., Gossop, Marsden, 
Stewart, & Kidd, 2003; Prendergast, Podus, Chang, & Urada, 2002) and to reduce 
associated crime (e.g., Ettner et al., 2006; Godfrey, Stewart, & Gossop, 2004). 
Conversely, research indicates that enforcement efforts are only minimally successful in 
reducing drug use and related crime (Cunningham & Liu, 2003; Degenhart, Reuter, 
Collins, & Hall, 2005).  
Although researchers have declared that “treatment works” overall, studies 
indicate that outcome results differ according to treatment modality. For example, a 
multisite outcome study conducted Hubbard et al. (1997) examined four different 
treatment modalities: long-term residential (LTR), outpatient methadone (OMT), 
outpatient drug-free (ODF), and short-term inpatient (STI). Results showed that clients 
generally reduced substance use in all groups at 1-year follow-up, although this result 
was not as strong for the STI group. Additionally, those in the LTR group showed 
reductions in crime and increases in full-time employment compared to other groups. 
Although these findings imply that longer, more intense treatment may yield better 
outcomes, such results are largely contradicted in reviews of existing literature, such as 
one conducted by Miller and Hester (1986), who examined 12 controlled studies looking 
the impact of treatment length on outcome. In general, brief interventions appear to work 
about as well as long-term inpatient treatment (Roth & Fonagy, 2005). Because inpatient 
treatment is so much more costly, this modality is no longer considered to be as cost 
effective as other formats to treat addictive behaviors; thus, spending on inpatient 
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treatment has been on the decline since the late 1980s (Meara & Frank, 2005). It is not 
entirely clear why few discernable differences in outcome have been found between in- 
and outpatient treatments. However, one could speculate that individuals attending 
outpatient treatment may learn to better generalize skills learned in treatment into their 
existing lives, whereas those in a controlled, inpatient setting may not. It is also possible 
that these different modalities serve different populations, with individuals enrolled in 
inpatient treatment evidencing greater severity of problems at the outset than those 
enrolled in less intensive treatment programs. 
As mentioned above, family has been found to be an etiological factor in 
substance abuse (i.e., the “family disease” concept). From this perspective, it seems 
logical that treatment of the whole family is indicated. In fact, Saatcioglu et al. (2006) 
suggested that this family disease “requires joint treatment of the family members” (p. 
125). Interestingly, these same authors did not discuss specific family treatments that 
encompassed the theoretical perspective they proposed. Furthermore, there appears to be 
a dearth of information about family approaches to substance abuse treatment that 
incorporate a family disease model. The closest modality outlined in the literature was the 
“companion” 12-step programs, which of course use the disease model as their 
orientation. 
Groups such as Al-Anon, Nar-Anon, and Alateen are not family therapy per se. 
Instead, such groups were designed as support-based groups for families of individuals 
with substance use disorders. These informal groups merit a brief discussion primarily 
because they are some of the most widely used treatment services for families of 
substance abusers. Perhaps these groups have become and remain so highly utilized 
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because attendance in such groups has been shown to improve marital adjustment 
(Keinz, Schwartz, Trench, & Houlihan, 1995) and to reduce the level of reported 
personal problems (Barber & Glibertson, 1996). Although mutual self-help groups 
appear to be helpful to the family members who attend, such groups are not surprisingly 
ineffective at engaging the substance abuser in treatment. For example, Al-Anon has 
been shown to be unsuccessful as a way to engage drinkers into treatment (Barber & 
Glibertson, 1996). Similarly, Nar-Anon has shown to be ineffective at engaging drug 
users into treatment (Meyers, Miller, Smith, & Tonigan, 2002). Because these mutual 
self-help groups only seem to be successful as group support for family, but not for the 
substance abuser themselves, it is helpful to consider how else family members can be 
integrated into treatment, given that this factor may be a powerful one in increasing 
motivation for treatment.  
Behavioral Couples Therapy (BCT) is one of the most researched treatments for 
substance use disorders that includes and emphasizes family, the partner or spouse in 
particular. This treatment works “directly to increase relationship factors conducive to 
abstinence” (Birchler, Fals-Stewart, & O’Farrell, 2005, p. 256). The empirical backing 
for BCT is quite strong. Although family interventions are largely absent from 
empirically supported treatment (EST) lists (Alexander, Sexton, & Robbins, 2002), 
there has been a great deal of efficacy research done with BCT and substance abuse. An 
abundance of BCT outcome studies have been done with alcohol users, many of which 
indicated the efficacy of this treatment over individual therapy, even up to 24 months 
post treatment (for a review, see O’Farrell & Fals-Stewart, 2000). Furthermore, 
research that compares the effects of BCT and individual therapy on domestic violence 
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in alcohol users has shown that the BCT group reports significantly less male-to-female 
aggression post follow-up (Fals-Stewart, Kashdan, O’Farrell, & Birchler, 2002).  
Randomized studies on BCT for drug abuse date back to 1996 (Fals-Stewart, 
Birchler, & O’Farrell). This research showed that drug-abusing males who took part in 
BCT had significantly fewer relapses and days of drug use, as well as more positive 
relationship outcomes than participants who attended individual treatment only. 
Subsequently, other BCT outcome studies with drug abusers have shown favorable 
results for this treatment (O’Farrell & Fals-Stewart, 2000). Similar to research done 
with alcohol abusers, BCT for drug abusers also appears to have a lowering effect on 
partner domestic violence (O’Farrell & Fals-Stewart, 2000).  
Finally, BCT has been shown to be cost effective for both alcohol and drug 
abusers compared with individual treatment. For example, BCT targeting drug abusing 
males has been shown to reduce social costs (e.g., drug-related health care, use of the 
criminal justice system, etc.), resulting in a higher average cost savings than individual 
therapy (Fals-Stewart, O’Farrell, & Birchler, 1997). The costs savings associated with 
BCT for alcohol abuse appear to be similar, such that significant reductions in hospital 
and jail stays are associated with BCT (O’Farrell et al., 1996).  
One major limitation of BCT is that the treatment does not include children or 
other members of the family. Excluding children from treatment may have two specific 
negative impacts: 1) family issues related to substance abuse may go disregarded, and 
2) parents have to find childcare for their children during treatment. Conners, Bradley, 
Whiteside-Mansell, and Crone (2001) discussed a treatment designed to target the latter 
of the aforementioned concerns. Specifically, these researchers examined an inpatient 
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treatment in which both crack cocaine abusing mothers and their children participated. 
Treatment consisted of both traditional substance abuse techniques (e.g., 12-step, 
relapse prevention, drug and alcohol psychoeducation), as well as aspects directed at 
family strengthening (e.g., parenting education and support, women in relationships, 
family dynamics in recovery). Additionally, services were provided for the children 
such as school programming and mental health treatment. The researchers compared 
the mothers and children who completed treatment to those families who dropped out. 
Follow-up assessment occurred at four different time points. Results indicated more 
positive outcomes for treatment completers, as measured by family interaction skills, 
substance use, negative consequences of substance use, and employment and self-
efficacy. Although this study’s findings indicate a need for more research on this 
treatment modality (namely, including a control group in the research design), the 
initial outcome implies that keeping families together during treatment may have a 
positive effect.  
In addition to treatment modality, numerous specific treatment approaches have 
been tested for their efficacy in reducing substance use. Such trials typically focus on 
one substance of abuse for the major drugs of abuse (i.e., alcohol, cocaine, and opiates). 
Multiple effective treatment approaches have been identified. For those diagnosed with 
an alcohol use disorder, social skills training, relapse prevention, cue exposure, coping 
skills training, contingency management, and motivational interviewing have all been 
shown to be efficacious (Roth & Fonagy, 2005). Nevertheless, it is suggested that these 
individual treatments not be used on their own, but in combination or as part of a larger 
treatment package (Roth & Fonagy, 2005). Research looking at the differences between 
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various therapies has been inconclusive. However, efficacy and effectiveness studies 
provide support for the effectiveness of 12-Step oriented approaches (Donovan, 1999).  
Generally, these studies have found a positive relationship between 12-Step 
involvement and improvement on substance use outcomes for both alcohol and drug 
abusers, even over extended periods of time up to 16 years (Montgomery, Miller, & 
Tonigan, 1995; Kaskutas, Ammon et al. 2005; Moos & Moos 2005; Moos & Moos 
2006).  Weiss and colleagues found that active involvement in self-help activities (as 
opposed to meeting attendance) in a given month predicted fewer days of cocaine use 
in the next month (2005). 
Also, Project MATCH (a group that examined outcomes of matching treatment 
type to client characteristics) found that people receiving twelve-step facilitation 
treatment had higher rates of abstinence than those in cognitive-behavioral or 
motivational enhancement therapies (Project MATCH Research Group, 1998). Also 
exemplified in these data was that attempts to match clients to treatment based on specific 
variables were unsuccessful. 
One concept related to the idea of treatment matching is treatment choice. While 
there appear to be a wide variety of possible treatments available for those who abuse 
substances, it is unclear what types of treatment people prefer. Furthermore, research that 
looks at how treatment choice affects treatment retention or outcome is sparse, but not 
absent. Adamson, Sellman, and Dore (2005) found that alcohol dependent participants 
tended to prefer motivational enhancement therapy over non-directive reflective listening. 
However, there was not a significant association between treatment preference and 
treatment outcome (measured in client satisfaction with treatment, treatment attendance, 
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and rates of drinking at 6 month follow-up). Similar results indicating that treatment 
choice (compared to being randomly assigned to at treatment) has little bearing on 
treatment outcome have been exemplified elsewhere as well (Ojehagen & Berglund, 
1992; Sterling et al., 1997). Although this research appears to nullify the importance of 
treatment choice, the results indicate that treatment – in whatever form – seems to have 
an appreciable effect on outcome.  
Perhaps because existing data show results indicating that treatment is an 
effective option, many legal justice systems across the country have developed drug court 
treatment programs as an intervention aimed at substance abusing perpetrators of crime. 
While treatment received through drug court interventions may not differ from traditional 
in- and outpatient treatment modalities, the referral process is unique. Specifically, some 
jurisdictions give the option for people arrested with drug-related crimes to get treatment, 
as opposed to incarceration. This kind of combination of criminal justice and treatment 
intervention has promising outcomes. 
Gottfredson, Najaka, Kearley, and Rocha (2006) compared people randomly 
assigned to either a drug court treatment group or control group, with results indicating 
lower rates of recidivism for the treatment group. This study indicates that reductions in 
crime can be achieved through drug court programming, and chalks up another “win” for 
treatment effectiveness. Other research indicates that individuals involved in programs 
such as drug court show reductions in future incarceration, associated legal costs, and 
utilization of mental health services compared to a control group not receiving drug court 
services (Logan et al., 2004). This same study showed that those attending Drug Court 
programs had increased rates of child support payments and overall earnings from legal 
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sources. Thus, the benefits experienced by the individual who attends a Drug Court 
program also translate into a cost-benefit for society.  
 For all the people who do find their way to treatment, either via the drug court 
system or by some other mechanism, a substantially larger proportion of people need 
treatment but do not receive it.  The National Survey on Drug Use and Health (NSDUH; 
Substance Abuse and Mental Health Services Administration; SAMHSA, 2006) estimates 
that 23.2 million, or 9.5% of the U.S. population age 12 or older, needs drug treatment 
based on DSM-IV criteria. Within this group, only about 2.3 million individuals actually 
received treatment in the past year at a facility specializing in substance abuse. What this 
may mean is that the high percentage of substance abusers who do not receive treatment 
may continue to incur social costs, such as those related to crime or employment 
difficulties. Because a disparity exists between those who need treatment and those who 
actually receive it, there is a need to research how to channel these individuals into a 
treatment setting.  
Motivation for treatment 
 The question of what motivates substance users to enter treatment (or what 
prevents them from entering treatment) is an important area to explore.  Previous research 
points us in the direction of the factors that lead people to enter treatment: 1) external 
factors, or factors that are beyond the person’s control, such as legal mandates; 2) internal 
factors, or motivation of the individual to seek treatment; and 3) diminished barriers to 
treatment, such as employing outreach methods in a community that help facilitate 
treatment seeking. Each of these factors can increase or decrease one’s propensity to seek 
treatment and will be discussed below. 
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 External factors. In terms of substance abuse treatment, drug court intervention 
programs are probably the most widely used tool for increasing treatment seeking and 
admission. As mentioned above, there is evidence that these programs work relatively 
well at lowering rates of recidivism and drug use. However, it is unclear how to tease 
apart the obvious external factors from internal motivation (when a person seeks out help 
or change) which may be operating simultaneously. The Baltimore City Drug Treatment 
Court program as described by Gottfredson et al. (2006), for example, only accepts 
clients who express interest in getting treatment, and the defendant must be assessed and 
recommended for the program based on the assessment. Here, the client must possess 
enough internal motivation in order to comply with the demands of the external 
motivator.    
 Other examples of external factors include additional social control tactics 
(besides legal mandates), such as coercion by family or friends to change substance using 
behavior in the form of informal mandates (e.g., ultimatums, threats; Gerdner & 
Holmberg, 2000; Polcin & Weisner, 1999). Therefore, examining interventions involving 
family members targeting substance abusing family members is a useful endeavor. There 
are several examples of formal intervention strategies (i.e. professionally guided) 
involving family members; existing research on the effectiveness these techniques is 
described here.  
 The Johnson Intervention (JI) was created in the 1960s as a reaction to the 
“loving detachment” approach accepted at the time, popularized by groups such as Al-
Anon, Nar-Anon, and Alateen (Fernandez, Begley, & Marlatt, 2006). JI is a technique 
in which family members confront the alcohol or drug user about the harm his or her 
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substance abuse is having. Ideally, the family provides treatment options, after which 
the person undergoing the intervention would choose one of these options to attend. 
While the intervention itself is carried out by family members, the preparation and 
practice are overseen by a professional. Although JI became widely used by 
organizations such as the U.S. Navy and employee assistance programs (Johnson, 1986, 
as cited in Fernandez, Marlatt, & Begley, 2006), data do not support its effectiveness. 
For example, one study (Miller, Meyers, & Tonigan, 1999) found treatment 
engagement success rates for JI were around 23%. Furthermore, Liepman, Nirenberg, 
and Begin (1989) found that the majority (72%) of families who were given a choice 
between carrying out JI or not chose not to because it felt too controversial and 
coercive.  Nonetheless, one research study has found JI to be effective, showing 90% 
success rate in treatment engagement (Logan, 1983, as cited in Fernandez et al., 2006). 
Although this study was questioned methodologically, this outlying result may indicate 
certain strengths inherent in the JI.  
 A Relational Intervention Sequences for Engagement (ARISE) is another 
intervention strategy that takes selected aspects of JI and combines them with other 
factors to produce a more comprehensive model of intervention. (The original 
intervention was called Albany-Rochester Interventional Sequence for Engagement; for a 
full description, see Garrett, Landau-Stanton, Stanton, Stellano-Kabat, and Stellano-
Kabat, 1997). One of the factors that differentiates ARISE from JI is the inclusion (or 
invitation for inclusion) of the individual substance abuser in the intervention strategy. 
During Stage 1 of ARISE’s three-stage approach, the concerned family member 
coordinates a meeting with the identified client and others concerned about the person’s 
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substance use. The substance abuser can choose to take part in this meeting or not. Stage 
2 consists of assessment of the person’s problem and treatment planning. Again, the 
identified client can choose whether or not to attend this part. If the substance abuser has 
not chosen to participate in the intervention process during the first two stages, the group 
stages a JI-like, confrontational intervention (Stage 3). Although there appears to be only 
one study examining the effectiveness of a manualized version of ARISE, the data 
indicated positive results (Landau et al., 2004). Specifically, these researchers found an 
overall success rate of 82.7%, most of which (55%) were engaged in treatment by the end 
of Stage 1. 
Mandates from employers and social service agencies can also be seen as external 
motivating factors. Finally, the desire to reduce drug tolerance may motivate people to 
seek treatment (this may be more of a factor for those who use opiates than for those who 
use other substances). Reducing drug tolerance is another example of the ambiguity 
between internal and external factors: a person wanting to reduce drug tolerance may 
appear to be motivated by a desire to change his or ways, when in fact the motivation is 
to avoid withdrawal symptoms and to ensure that later drug use will result in feeling the 
effects of the substance. Data about these last two examples of external motivators are 
less available, possibly because they are seldom assessed directly. Nonetheless, 
information about such motivators could shed light on some of the mechanisms by which 
people enter treatment.  
Individuals addicted to drugs often contend with a variety of medical problems 
related to their substance use (i.e., abscesses, hypertension). Reduction in substance use 
could also help people reduce their health problems, thus physical problems (and the 
   
 
21 
 
amelioration of them through abstinence or harm reduction) could be seen as a motivator. 
Whether this is an external motivator from a client perspective is unclear. Deci and Ryan 
(1985) have defined this construct more narrowly, such that treatment is sought because 
of coercion from an outside body. Nonetheless, some medical problems are ones that may 
be outside the person’s immediate control (e.g., chronic pain) and therefore could be 
viewed as external. Research findings indicating that transient medical problems are 
related to “transient” increases in motivation reinforce the idea that physical problems are 
indeed external forms of motivation. For example, O’Toole, Pollini, Ford, and Bigelow 
(2006) conducted a study at an acute medical setting at which substance abusers were 
interviewed. Results showed that medical problems were a motivator for seeking 
treatment. However, the researchers found that those citing physical complaints as their 
primary motivator had lower treatment completion rates. These results support the idea 
that external motivators do not work as well as intrinsic motivation in terms of keeping 
people engaged in treatment.   
 In a similar study, Pollini, O’Toole, Ford, and Bigelow (2006) found that health 
problems were associated with readiness to change in a population of active substance 
abusers admitted to an acute care hospital. Moreover, these researchers found that 
psychological symptoms were also related to motivation. Specifically, bipolar disorder 
and reported depression were related to higher levels of motivation for treatment seeking. 
Like medical problems, defining psychological disorders as an external motivator is not 
completely straightforward. Diagnosable conditions, like major depressive disorder, may 
be complicated by a person’s feelings of remorse or worry about his or her use. These 
feelings may contribute more to a sense of internal motivation. A more comprehensive 
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discussion regarding comorbidity and motivation occurs in the section on internal factors 
below. 
 Internal factors.  Internal motivation can be likened to intrinsic motivation, which 
has been defined by Ryan and Deci (2000) as “doing something because it is inherently 
interesting or enjoyable” (p. 55). When applied to changing substance abuse behaviors, 
internal motivation occurs when individuals seek out help and identify with the goals of 
treatment. As mentioned above, the distinction between internal and external motivators 
is not always entirely clear. Although internal motivation may seem like a distinct 
construct from external motivation, the two concepts are sometimes linked. For example, 
Ryan, Plan, and O’Malley examined alcohol abusers entering treatment and found that 
people who reported both internal and external motivators for treatment exemplified the 
best treatment outcome, indicating that the combination of these two motivators is greater 
than each one by itself. Furthermore, from a self-determination theory perspective (Deci 
& Ryan, 1985), increases in external motivators may undermine a person’s internal 
motivation because of the perception that autonomy is being taken away. Wild, 
Cunningham, and Ryan (2006) found support for self-determination theory in their study, 
which gathered data on referral sources (objective measure of pressure for treatment), 
perceived coercion (subjective interpretation of pressure for treatment), motivation for 
treatment, and client engagement. Results indicated that the objective referral source was 
not found to be related to motivation and client engagement, whereas participants’ 
interpretation of perceived coercion predicted both motivation and treatment outcome.  
 Although external and internal motivations appear to be related, internal 
motivation has been more strongly linked to positive treatment outcomes (Ryan & Deci, 
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2000; Ryan et al., 1995). This type of motivation might change a person’s treatment 
seeking or desire to seek change. Lack of motivation for treatment has been cited as one 
of the main factors in treatment dropout (Miller, 1985; Ryan, Plant, & O’Malley, 1995). 
Motivation as a construct has been examined in the literature primarily using the 
transtheoretical model of change (TTM) or simply the stages of change model (Prochaska 
& DiClemente, 1986). This model puts forward the idea that there are five stages 
involved in changing a behavior, each requiring alterations in attitude in order to progress 
to the next stage. The authors depict change as a cycle, and they contend that it is quite 
normal for people to require several trips through the stages in order to make lasting 
change. The authors conceptualize that the initial stage of change is one in which a 
person is “precontemplative,” or unaware that she or he has a need to change. Using this 
model, it is thought that people progress to a “contemplative” stage, aptly named for 
people in this group who are considering the possibility of change. Once an individual 
moves from contemplating to actively taking steps toward changing behavior, he or she is 
considered to be in the “active” stage. A relapse (return to the previously problematic 
level of behavior) or lapse (a “slip” back to using on one or more occasions) may or may 
not follow the active stage, in which people might make a foray back into the behavior 
being changed. Then, the person may enter back through the cycle at either at the 
precontemplation stage, or at another stage. For a substance abuser, it is important to 
understand where he or she is in terms of stage of change in order to gauge treatment 
seeking or change behavior.   
 Related to motivation (and helpful in considering factors associated with internal 
factors for change) is the idea of spontaneous remission, also called “natural recovery”, in 
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which people change their substance use without treatment. Cognitive evaluation, or 
weighing the pros and cons of substance use (Miller & Rollnick, 2002), has been shown 
to be the primary reason for quitting substance use in individuals who undergo 
spontaneous remission (e.g. Toneatto, Sobell, Sobell & Rubel, 1999; Sobell et al., 2001). 
The cited research sheds light on factors that precipitate behavior change in cocaine and 
alcohol users, which might be a good model for other substance users.  
 Factors such as cognitive evaluation should also be considered in individuals for 
whom natural recovery does not seem possible, but may still be motivated to change. For 
these people, seeking professional help would be the behavioral manifestation of 
motivation. Factors related to available treatments may have an effect on a person’s 
motivation for change. That is, if aspects of a certain treatment approach were more 
appealing than an alternative treatment, the person might be more motivated to try out the 
treatment of choice. As mentioned above, literature on treatment choice has shown 
virtually no relationship between treatment outcome and treatment choice, although these 
studies did not explore how motivation may have played a role. 
 Different treatment approaches seem to appeal to people at varying levels of 
motivation. For example, cognitive evaluation (described above) is one principle used in 
Motivational Interviewing (Miller & Rollnick, 2002), an intervention strategy designed to 
move people into a contemplative or preparation stage of behavior change. Thus, this 
model is not designed to require a commitment to complete abstinence from clients, even 
if that may be a longer term goal. Efficacy of this type of intervention has been 
demonstrated by a number of studies looking at alcohol, cocaine and non-substance use 
related behaviors such as weight loss (Miller & Rollnick, 2002). In practice, motivational 
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interviewing can be viewed as a harm-reduction approach, since individuals are not 
expected to be motivated to quit substance use completely. Conversely, other treatments 
require higher levels of motivation, or at least commitment, from the outset, like 
treatments expecting complete abstinence, such as the 12-Step approach. Although it 
seems intuitive that those individuals more motivated to change would choose an 
abstinence-based approach, which requires a more significant change in behavior in 
comparison to harm-reduction treatments, this notion has not been tested empirically.  
  Barriers to treatment.  Even if an individual is highly motivated to change his or 
her behavior and seek treatment, there still may be obstacles present preventing him or 
her from obtaining treatment. Thus, factors related to systems within society – whether 
they be barriers or aids – may ultimately be related to motivation for treatment. Financial 
barriers represent one arena that prohibits a segment of substance abusers from entering 
treatment. Although public resources cover much of overall spending for treatment, 
45.3% of individuals who received drug abuse treatment in 2005 reported paying for it 
via their “own savings or earnings” (SAMHSA, 2006). Furthermore, among the 
individuals who made an effort to receive treatment but did not do so, the most often 
cited reason for not receiving drug treatment was cost of insurance (44.4%), followed by 
other access barriers, such as lack of transportation, or few openings in treatment 
programs (21.2%; SAMHSA, 2006). Even for those who do depend on government 
funding to pay for treatment, these programs are vulnerable to changing state and federal 
budgets, potentially jeopardizing this group’s chances at obtaining treatment.  
An intermediary referral source is sometimes the mechanism by which people 
become affiliated with treatment. For example, needle exchange programs for opiate 
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addicted individuals have been shown to be an effective bridge to treatment (Heimer, 
1998). However, geographic characteristics may undermine the use of those strategies. 
Needle exchanges tend to occur in urban areas with well-established outreach systems in 
place.  
Rural states like Montana have outlawed needle exchanges, forcing them to 
operate underground. Therefore, Montana has no access to such services, even though 
there is arguably a potential need for them. Although opiate users typically comprise the 
majority of needle change consumers, methamphetamine users could also make use of 
needle exchanges, given the high rate of methamphetamine users who use intravenously 
(Wada, Greberman, Konuma, & Hirai, 1999). Methamphetamine is especially prevalent 
in rural areas like Montana; qualitative indicators have show that methamphetamine use 
is moving away from urban areas to more rural areas (Community Epidemiology Work 
Group [CEWG], 2008).  
 The presence of an intermediary referral source may be one strategy for assisting 
people in accessing treatment for their addiction problems. Conversely, the absence of 
these services necessarily means the community is lacking at least one means of 
facilitating treatment seeking behavior. Other barriers to substance abuse treatment are 
well-documented in the literature. For example, Appel, Ellison, Jansky and Oldak (2004) 
interviewed street IV drug users to determine what they thought were barriers to 
treatment. The top five cited barriers included family or personal issues, lack of 
motivation, lack of insurance or Medicaid coverage, aversion to treatment, and lack of 
personal identification. Other research showed that lack of health insurance prevented 
people from using a treatment referral (Riley, Safaeian, Strathdee, Beilenson, & Vlahov, 
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2002). Additionally, this study found that living too far away from the treatment facility, 
employment schedules, incarceration, lack of money, and fear of paperwork were other 
factors preventing individuals from following through on a referral. While both of these 
studies involved opiate addicted participants, it is possible that these same barriers apply 
to other types of substance users that are more commonly found in Montana.    
Another factor that might affect people’s treatment- or change-seeking behavior is 
exposure to a discussion about substance use. That is, having an opportunity simply to 
talk about his or her substance use patterns could promote a person to move in the 
direction of change. While the individual’s movement from non-change-seeking to 
change-seeking is an internal factor, the mechanism by which that change is facilitated – 
exposure to the discussion – can be conceptualized as an outreach effort, or aid for people 
to bring about the process of change. 
 Motivation and comorbidity. It is common for those who have substance use 
disorders to also have another psychological disorder. Of the most commonly co-
occurring disorders with substance abuse is major depressive disorder; it has been found 
that 24% of persons with major depression have substance abuse problems (Kessler et al., 
2003). Conversely, individuals diagnosed with a substance use disorder tend to have 
higher rates of co-occurring psychiatric diagnosis. For example, one study indicated that 
a sample of adolescents reporting the misuse of prescription pain relievers were 1.8 times 
more likely to use mental health services than nonusers (Wu, Ringwalt, Mannelli, & 
Paktar, 2008). The presence of a disorder such as depression appears to complicate the 
course of a person’s substance use disorder in several important ways. Specifically, 
outcome studies have shown that treatment seeking alcohol abusers with comorbid 
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depression had significantly lower rates of abstinence following treatment compared to a 
non-comorbid group (Driessen et al, 2001; Greenfield et al., 1998). Similar results have 
been found with abusers of drugs other than alcohol (Dodge, Sindelar, & Sinha, 2005). 
While such findings imply that depression symptoms may be a significant factor related 
to substance abuse treatment outcomes, there is also evidence to suggest that individuals 
experiencing depression might have better outcomes in the short term. For example, one 
study found better retention among depressed substance abusers (McKay et al. 2002). 
This result may be due in part to the nature of an individual’s dysphoria, which may in 
fact motivate him or her to attend treatment to reduce such symptoms.  
 Although speculations can be made about the interaction between psychological 
distress and its influence on help seeking, little is known about the specific motivational 
mechanism of comorbid disorders and how they may affect motivation for treatment- or 
change-seeking behavior in substance abusers. The two studies that do examine the 
relationship between motivation to change drinking behavior and presence of a comorbid 
disorder (depression and anxiety) use samples of only alcohol users (Grothues et al., 
2005; Velasquez, Carbonari, & DiClemente, 1999). In general, results of these studies 
indicate that increased psychiatric severity was related to higher levels of intention to 
change. While these results help to inform theories about how comorbid diagnoses relate 
to motivation for change, more research is needed to better understand how individuals 
using illicit or multiple substances may differ from those with an alcohol use disorder. 
Additionally, it is unclear how other comorbidities, such as antisocial personality 
disorder, may complicate the picture regarding motivation.   
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Hypotheses 
The preceding literature review suggests a complex array of possible connections 
between substance abuse treatment seeking behavior, external and internal motivation, 
and barriers to treatment. The present study extends research on treatment seeking 
behavior by examining a population of non-treatment seeking inmates.  A large amount 
of substance abuse research uses treatment-seeking samples, and one goal of this study 
was to gather information on individuals who have a substance abuse problem but have 
not sought out treatment. Thus, the first aim of this study was to describe a sample of 
substance abusing individuals who have recently been actively using. 
Although there is a body of literature describing motivating factors among 
substance users, less is known about how motivated substance abusing inmates are to 
enter treatment. We wanted to find out: 1) how motivated incarcerated substance users 
are to change their behavior; 2) what factors are related to levels of motivation; and 3) if 
they are motivated, what are the factors prohibiting them from seeking treatment? 
Alternatively, what could be put in place as outreach to facilitate the transition from 
active user to treatment-seeker? Toward this aim, the factors that both inhibit and 
promote treatment seeking were explored.  In this study, we tested the hypotheses related 
to the psychosocial factors we believed to be related to participants’ motivation for 
treatment: psychological distress, physical problems, primary drug of abuse, duration of 
addiction, and family connectedness. Based on this notion, we hypothesized: 
1. The aforementioned predictor variables will, as a group, predict level of 
motivation. We also wished to determine which factors have the greatest effect on 
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motivation. There was no specific prediction about which variable will have the 
strongest impact.  
2. Psychological distress will serve as a motivator for seeking treatment: motivation 
for changing substance abuse behavior will be higher for those who demonstrate 
higher levels of psychological distress.  
3. Physical problems will affect motivation to change substance abuse behavior. 
Medical issues may serve to increase motivation, but the hypothesis here is non-
directional because there is evidence that the influence of physical problems on 
motivation exists, but is transient.  
4. Motivation to change substance use behavior will differ based on participants’ 
primary drug of abuse. The specific hypothesis is that those who primarily use 
drugs that are considered to have a more potential for physical dependency (e.g., 
opiates and alcohol) will have a higher motivation to change than those who use 
less addictive drugs (e.g., marijuana). This hypothesis is partially based on 
existing literature suggesting that cocaine users have higher motivation for 
treatment-seeking than do primary marijuana users (Levin et al., 2006).  
5. Duration of addiction will be related to motivation for treatment seeking, such 
that the longer someone has been abusing substances, the more motivated that 
person will be for entering treatment. While this hypothesis has not been 
substantiated in the literature directly, there is evidence to suggest that older 
individuals (connoting more years of substance abuse) have more motivation for 
treatment than younger individuals (O’Toole et al., 2006).  
   
 
31 
 
6. Increased family discord will serve as a motivator to seek treatment. In other 
words, more problems within family relationships will be related to a higher level 
of motivation to change problematic substance abuse behavior.  
7. Higher levels of motivation will be related to choosing an abstinence-based 
(versus harm reduction) model of treatment in a hypothetical treatment choice. 
Testing this hypothesis is important because if a person is able to choose one 
treatment over another, that individual may be more motivated to attend and 
complete the treatment of choice. Since there is virtually no empirical basis for 
knowing what types of substance abuse treatments people prefer, we also tested 
whether one treatment is chosen more often than another. 
There were no a priori hypotheses regarding barriers to treatment, as this is an 
exploratory question among the population being investigated. Nonetheless, this 
information could prove invaluable for the Western Montana community. To best 
identify barriers, we explored the data in two ways. First, items on the Barriers 
Questionnaire (Center on Alcoholism, Substance Abuse and Addictions, 1995) were 
examined to determine the percentage of participants endorsing each item. Second, we 
divided the items into five categories representing groups of barriers. Using a previous 
study as a model for factors regarding barriers to treatment (Rockloff & Schofield, 2004), 
we constructed our own, similar set of factors including self-perception, stigma, cost, 
motivation, negative perception of treatment, and fear of outside consequences. Scores on 
these factors were correlated with the following variables: age, readiness to change 
substance use behavior, duration of addiction, psychological distress, family discord, and 
severity of medical problems.  
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Looking at etiological factors was another part of this study, even though this 
topic area is not directly related to the authors’ main hypotheses. We chose to conduct 
exploratory analyses that allowed us to examine etiology of addiction in our sample. 
Specifically, we examined age of first use of substances, the age at which drug or alcohol 
use became problematic, and how individuals were introduced to various drugs.  
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Methods 
 In this study, the investigators recruited recently incarcerated substance abusers to 
assess this group in a number of areas. The variables of interest consisted of those 
relating to factors that influence a person’s decision to seek treatment. Internal factors 
(motivation), external factors, and systemic barriers factors were examined.   
Participants 
Fifty-one substance abusers incarcerated at Missoula County Detention Facility in 
Missoula, Montana were recruited for participation in this study. This sample size was 
chosen on the basis of literature exemplifying similar studies (i.e., used an incarcerated 
population and examined substance use behavior) with similar sample sizes (e.g., 
Goodrum, Staton, Leukefeld, Webster, & Purvis, 2003; Seal et al., 2004;  Staton-Tindall, 
Royse, & Leukefeld, 2007). Participants had to meet the following criteria in order to 
take part in the study: 1) 18 years of age or older, 2) have the ability to speak English, 3) 
have been incarcerated on a substance-related charge (e.g., DUI, possession of an illegal 
substance), and 4) have not been enrolled in substance abuse treatment or attending 12-
Step meetings, such as Alcoholics Anonymous, at any time within the past year.  
Setting  
 Recruitment and data collection occurred at the Missoula County Detention 
Facility. There were two main reasons for conducting research in this setting. First, data 
indicate that a large percentage of jail inmates test positive for drug use, as indicated by 
the ADAM data (National Institute of Justice, 2003). Therefore, we believed that a 
sample of current substance abusers would be relatively easy to obtain at this location. 
The second reason for collecting data in a jail setting relates to the difficulty of recruiting 
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people who are current substance abusers. This population is difficult to target for 
recruitment because their activities are largely underground, and consequently invisible 
to mainstream society. Controlled environments, such as jails, typically have a high 
percentage of individuals who currently suffer from substance abuse problems, but may 
not be in a treatment setting. It is this “pretreatment” group that the investigators targeted 
in order to better understand why they have not chosen to seek treatment. Ideally, 
targeted sampling in the community would be the preferred method of recruitment, as this 
has been shown to have better generalizability than sampling from institutions 
(Chitwood, Rivers, Comerford, & McBride, 1993). Plus, institutions such as jails may 
provide substance abusing individuals with a place to reflect on their current situation, 
thus altering their motivation for treatment. Nonetheless, this group was deemed more 
favorable than one already connected to treatment, where individuals who have 
previously made the decision to enter treatment may retrospectively view their 
motivation for treatment inaccurately. 
Procedures  
 Participants were recruited from Missoula County Detention Facility in Missoula, 
Montana. The investigators kept track of individuals arrested and booked by checking the 
online roster of inmates. Inmates arrested on a drug- or alcohol-related charge were sent 
recruitment letters, explaining the study and asking them to mail back the accompanying 
return letter indicating interest in the study. Between June 2007 and March 2008, 369 
individuals were identified who met the study criteria. Because many had been 
discharged before a letter could be sent, only 165 prisoners were sent recruitment letters.  
Of 165 letters sent, 38% were returned. Once the research team received a return letter, 
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an interviewer went to Missoula County Detention Facility to meet with the potential 
participant. Prior to participating in the study, participants were provided with a complete 
description of the study and written informed consent was obtained. In order to ensure 
confidentiality, the interviewers met with inmates in special rooms typically delegated for 
lawyer-inmate discussions. No jail personnel were present. All interviews occurred at 
Missoula County Detention Facility took approximately two hours and consisted of the 
measures described below.   
Measures 
Each participant recruited into the study underwent an assessment consisting of 
six measures: the Addiction Severity Index 5th edition (ASI: McLellan et al., 1992), the 
Beck Depression Inventory-II (BDI-II: Beck, Steer, & Brown, 1996), the Brief Symptom 
Inventory (BSI: Derogatis, 1992), the University of Rhode Island Change Assessment 
Scale (URICA: DiClemente & Hughes, 1990), the Barriers Questionnaire (Center on 
Alcoholism, Substance Abuse and Addictions, 1995), and two exploratory measures 
composed by the primary investigator, one of which is qualitative in nature and is 
designed to get a better picture of etiology of addiction; the other is a forced treatment 
choice questionnaire.   
Overview of problems related to substance use: The ASI is a semi-structured 
clinical interview that gathers demographic information as well as data regarding seven 
domains of the individual’s life that may or may not be affected by drugs and/or alcohol.  
These seven areas include medical history, employment functioning, drug and alcohol 
use, legal status, and family, social, and psychological functioning. For the purposes of 
the current study, we modified the ASI in two ways. First of all, we added a question that 
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asked participants to identify their sexual orientation. We believe this is an important 
demographic variable, and such data are seldom systematically collected in substance 
abuse research. The second way in which we altered the ASI was by omitting the 
questions in the psychiatric section that relate to suicidal thoughts or attempts. We 
excluded these questions at the request of the Missoula County Detention Facility; 
administrators were not comfortable with questions about suicidality, as interviewers 
would be unable to intervene if participants expressed any suicidal thoughts or intentions.  
The baseline ASI inquires about two time frames of clients’ lives: 1) entire 
lifetime and 2) the past 30 days. This instrument is not diagnostic in nature, but instead 
assesses how severely and in what areas drugs and/or alcohol have impacted the 
individual’s life. The ASI has several variables of interest we used during analysis, 
including demographic information, substance abuse history, and recent drug use. Also, a 
composite score was determined for each client on every domain of the ASI. Composite 
scores are comprised of several questions from each domain, which are then placed into 
an algorithmic function, resulting in a number between zero and one (McGahan, et al., 
1986). This score was used to measure the severity of problems in each domain; higher 
scores indicate higher level of impairment in a particular domain than lower scores.  
According to McLellan and his colleagues (1992), the ASI 5th Edition showed 
test-retest reliability coefficients of .83 or higher. An analysis of thirty-seven studies of 
the psychometric performance of the ASI, however, showed that test-retest reliability on 
composite scores ranged from “excellent” (.97) to “unsatisfactory” (.03), depending on 
the ASI domain being investigated (Mäkelä, 2004). For more reliable results, the 
developers of the ASI suggest interviewers undergo a 2-day training and must have 
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reasonable rapport with the interviewee (McLellan et al., 1992). Studies looking at the 
validity of the ASI have found moderate to strong correlations (r = .50-.70) between ASI 
composite scores and other measures of drug/alcohol use (Mäkelä, 2004). Because 
studies have shown some variability in the reliability and validity of the ASI, the research 
team was extensively trained in the ASI prior to study commencement. Also, frequent 
reliability meetings were held to prevent interviewer drift and ensure that ASI 
interviewers coded consistently.  
For this study, two interviewers completed all the interviews. The principal 
investigator has taken part in several two-day ASI trainings, and she has aided in training 
other researchers and clinicians in administration of this instrument. The second 
interviewer received ASI training from the principal investigator, which included one-on-
one consultation, watching a series of ASI training videos, observing interviews, and 
being observed and evaluated on administration of the instrument.  
Psychological symptoms. The ASI provided some psychologically relevant data 
including self-report of hallucinations, trouble controlling violent behavior, and the 
psychiatric status composite score. Other variables relating to psychological status came 
from the BDI-II and BSI. The BDI-II is typically a 21-item account of self-reported 
attitudes and symptoms characteristic of depression. The measure was shortened to 20 
items for the purposes of our project, leaving off the item regarding suicidal ideation as 
requested by the Missoula County Detention Facility. Each question is scored from 0 to 
3, relative to severity, yielding a total range between 0 and 63. BDI-II composite scores 
served as the variable of interest from this instrument. The reliability of the BDI, in terms 
of internal consistency, ranges from .73 to .92 (Devilly, 2004). The content of the BDI 
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was obtained by polling clinicians regarding symptoms of depressed patients (Beck et al., 
1961). Thus, the current BDI items and clinician ratings for depression are relatively 
consistent, with correlations ranging from .62 to .66 (Devilly, 2004).    
The BSI is a self-report inventory of 53 items related to psychological 
symptomatology, assessed with a five-point Likert scale (from ‘not at all’ = 0, to 
‘extremely often’ = 4). Additionally, this instrument has nine scales representing nine 
symptom dimensions (Somatization, Obsessive-Compulsive, Interpersonal Sensitivity, 
Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation, and Psychoticism). 
Scores on each scale were the variables of interest from this instrument. The range for the 
scores depends on the scale. For the Interpersonal Sensitivity scale, the range is between 
0 and 16. The Psychoticism, Paranoid Ideation, Phobic Anxiety, and Hostility scales have 
a range between 0 and 20. The Anxiety, Depression, and Obsession-Compulsion scales 
have a range between 0 and 24, and the Somatization scale has a range between 0 and 28. 
Derogatis and Melisaratos (1983) have reported that this instrument has coefficients of 
internal consistency ranging from 0.71 to 0.85 and test-retest reliability ranging from 0.68 
to 0.91. A Global Severity Index measures the participant’s overall level of psychological 
distress. 
We scored the BSI by adding ratings for subscale items and dividing by the 
number of items. These mean raw scores were transformed into T-scores (mean of 50 and 
standard deviation of 10) separately for women and men, based on the adult non-patient 
norms tables. Derogatis (1992) established the following two criteria for designating an 
individual as being positive for diagnosable psychopathology based on adult, non-patient 
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norms: a) a T-score for GSI of 63 or greater, or b) T-scores of 63 or greater on two or 
more subscales.  
Factors that influence change.  Two instruments were used to assess how 
motivated individuals are in changing their substance use and what reasons prevent them 
from seeking treatment.  The URICA is a 32-item instrument designed to assess readiness 
for change. Participants answered items on a 5-point Likert-type scale, through which 
participants rated agreement or disagreement with each statement. Items were grouped 
into four subscales, each with 8 items that correspond to Prochaska and DiClemente’s 
(1986) stages of change: 1) Precontemplation, characterized by lack of desire to change 
substance use behavior, 2) Contemplation, characterized by an understanding that a 
substance abuse issue is present and by thinking about changing this behavior, 3) Action, 
characterized by actively working to change substance use behavior, and 4) Maintenance, 
characterized by consolidation of changes one has made to substance abuse behavior. 
Items in this instrument describe attitudes, intentions and behaviors associated with 
changing a target behavior (e.g., drug use). The following is an item from the 
Precontemplation subscale of the URICA: “As far as I'm concerned, I don't have a 
drinking/drug problem that needs changing”. An example of an item on the 
Contemplation subscale is: “I’ve been thinking that I might want to change something 
about myself.”  
The relative merits and drawbacks of assigning individuals to a particular stage of 
change have been argued by researchers and clinicians alike (for a partial review, see 
DiClemente, Schlundt, & Gemmell, 2004). To address this, we used both a continuous 
variable, indicating change, and we categorized individuals into identifiable categories, 
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although only for descriptive purposes. The “Readiness score” (continuous variable 
ranging from − 2 to + 14) was calculated using the following URICA-subscale algorithm: 
summing the means for Contemplation, Action, and Maintenance subscales, then 
subtracting the Precontemplation subscale mean. This was the score used primarily in our 
analyses. Stage-of-change status was used to describe the sample, and we assigned to 
individuals using the following cutoff points: scores below 8 indicating 
Precontemplation, scores of 8 to 12 representing Contemplation, and scores above 12 
designating Preparation/Action (see DiClemente et al., 2004, p. 111). We also used these 
group designations to examine differences in psychological distress between stage of 
change groups. 
Psychometric analyses of the URICA reveal that the internal consistency has 
coefficient alphas from 0.79 to 0.89 for the four subscales (McConnaughy, DiClemente, 
Prochaska, and Velicer, 1989). Belding, Iguchi, and Lamb (1996) conducted research 
supporting the construct validity of the URICA through factor analysis. Furthermore, El-
Bassel, Schilling, Ivanoff, Chen, Hanson, and Bidassie found that the URICA’s stages of 
change subscales are associated with different behavioral profiles in drug-using 
incarcerated women.  
Finally, the Barriers Questionnaire is a 50-item self-administered questionnaire 
developed for purposes of determining reasons for not seeking treatment. Participants 
were asked to rate how specific factors may inhibit them from seeking treatment at this 
time on a scale of 0 to 3, with 0 representing “not at all” influential and 3 representing 
“very important.” According to the authors of this instrument (Miller & Tonigan, 2009), 
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the Barriers Questionnaire has not been scaled, and interpretation is therefore at the item 
level.   
Pathways to addiction. The Etiology of Addiction Questionnaire (Appendix A) is 
an exploratory measure that was used to gather information from research participants 
about the development of their difficulties with substance use.  For example, participants 
were asked who they were with the first time they used specific substances and how they 
perceived their environment and experiences with the substance. Some questions on this 
instrument are open-ended, thus providing the researcher with rich, qualitative 
information about the development of a person’s addiction. The aim here was to 
understand how etiological factors may have influenced their substance use. In a 
preliminary study (Peavy & Cochran, in preparation), this questionnaire was administered 
to a sample 50 of treatment-seeking substance abusers. Since this prior study was 
examining differences between methamphetamine and non-methamphetamine using 
substance abusers, the sample had an almost equal number of participants in each 
category (28 and 22, respectively). Participants’ responses to the questions were 
transcribed verbatim at the time of the interview. True to an inductive approach to 
qualitative analysis (Maxwell, 2005), we developed theoretical categories concurrent 
with data collection, solely based on interactions between interviewer and interviewee; no 
prior concepts were formulated. The principal investigator conducted all the interviews, 
and began developing ideas about the emerging themes early on in the data collection 
process. These themes were refined once all of the data were collected and the transcripts 
were read several times. After discussions with other researchers who read over the 
transcripts, the coding frame was finalized, which focused on factors related to drug use 
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initiation and development of problematic substance use. Three additional research 
assistants sorted each individual response into these theme categories. When at least two 
out of the three research assistants agreed on the categorization of an answer in a 
particular theme, the response was then counted as a response into that theme category. 
Results from this study indicate that there appear to be differences between 
methamphetamine users and non- methamphetamine users in terms of the development 
and maintenance of addiction. Familial influence, along with the properties of 
methamphetamine (namely its high addictive potential), seem to play a role in the 
escalation of its abuse and difficulties with quitting. Social factors play a larger role for 
individuals with a primary alcohol addiction in the reasons for why they use, as well as 
their reported difficulties in quitting. In the current study, responses were also coded into 
response categories similar to the initial study. Specifically, responses related 
family/social influences on first substance use were grouped; family and social influence 
was also a response category for participants’ reported reasons for quitting. Other 
response categories included: biological (properties of the drug) and psychological 
factors (vulnerability to depression or other disorders) in influencing addictive behaviors. 
Treatment choice. To assess which treatment philosophies people prefer, 
participants read a brief description of the treatment philosophies embodied in 
abstinence-based and harm reduction approaches (see Appendix B to view the measure in 
its entirety). Then, they were asked to choose a treatment philosophy. As an added 
question, participants were asked whether they would then opt out of treatment, or 
engage in the treatment of their choice. To get a sense of why individuals chose a 
particular treatment, participants were asked to provide a reason for their choice; this 
   
 
43 
 
qualitative piece of information was not analyzed formally, but is briefly discussed in the 
Discussion in order to supplement the quantitative findings. 
Analyses 
In order to examine the factors that predict motivation for change, a multiple 
linear regression was used. The regression equation involved five independent variables 
and the dependent variable to be used was the Readiness score on the URICA (described 
above). This analysis was employed to examine the relationships between motivation and 
the following five independent variables: 1) the BSI’s overall index score of severity of 
psychiatric distress (General Severity Index [GSI]) to determine the impact of 
psychological distress on motivation, 2) the medical section ASI composite score was 
entered into the model in order to examine the impact of physical problems on 
motivation, 3) the ASI composite scores for alcohol, 4) the ASI composite scores for drug 
use (both the alcohol and drug composite  scores are one measure of overall severity of 
substance use and include duration of addiction as a major part of the score), and 5) the 
ASI family/social section composite scores were added in to determine whether problems 
in this area predict motivation. The demographic variables of age, gender, and education 
were included as covariates, although these variables were found to be unrelated to the 
dependent variables.  
Additionally, the five aforementioned independent variables (GSI, and the ASI 
composite scores for the following sections: medical, alcohol, drug, and family/social) 
were entered into five separate regression models to examine each variable separately. It 
was predicted that that each independent variable will be a significant predictor of 
motivation for treatment.  
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In order to examine psychological distress in more detail, we calculated the BSI 
subscale scores and compared them between three groups, based on a person’s Readiness 
score: 1) Precontemplation indicated by scores below 8, 2) Contemplation indicated by 
scores between 8 and 12, and 3) Action/Preparation indicated by scores above 12.  
 Since we also predicted that motivation would differ based on primary drug of 
abuse, the sample was split into groups of primary problem substance, based on data from 
the ASI: 1) alcohol; 2) opiates; 3) methamphetamine; 4) marijuana; and 5) polysubstance 
abuser – no primary substance identified. Using the Readiness score on the URICA as the 
dependent variable, a one-way analysis of variance was run and planned comparisons 
were conducted to see how groups differ in terms of motivation. 
 Percentages of participants choosing their treatment approach (harm reduction or 
abstinence based) are reported. We conducted a Chi Square test to compare percentages 
of participants selecting “no treatment” (versus their treatment of choice), and whether 
the proportion was higher in a particular treatment choice category. To examine if higher 
rates of motivation were associated with choosing an abstinence-based approach, groups 
were separated into choice categories: abstinence-based and harm reduction, and we 
conducted an independent samples t-test, using the Readiness score on the URICA as the 
dependent variable. We predicted that the analysis would show that the group selecting 
abstinence-based treatment had a higher level of motivation than the group selecting 
harm reduction. 
 Barriers to treatment were investigated by noting the percentage of individuals 
endorsing each of the 50 items on the Barriers Questionnaire. The authors of this 
questionnaire indicated that the items have not been scaled, and they suggest that 
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interpretation should occur on an item level (Miller & Tonigan, 2009). However, in an 
effort to examine these data in the most comprehensive way, we opted to generate factors 
that represent six categories of barriers to treatment. The determined factors include: 1) 
self-perception not aligned with someone who needs treatment, 2) belief that others will 
stigmatize treatment attendees, 3) cost/availability of treatment, 4) lack of motivation to 
change substance use behavior, 5) negative perceptions about the treatment experience, 
and 6) fear of consequences (e.g., withdrawal symptoms related to stopping use or legal 
problems as a result of presenting to a treatment facility). We established these factors 
using the following methodology. First, we examined another study (Rockloff & 
Schofield, 2004) that used a measure similar to the Barriers Questionnaire, which the 
authors had altered to tap into attitudes toward gambling treatment. These authors used 
factor analysis to identify barriers, and we used three of their factors (stigma, cost, and 
availability, the two latter of which we collapsed into one category). The principal 
investigator designated items to each of these categories based on their content. We then 
developed three other theoretical categories based on the principal investigator’s review 
of the remaining items. Two additional research assistants sorted each individual item 
into these theme categories. When at least two out of the three coders (including the 
principal investigator) agreed on the categorization of an item within a particular 
category, the item was included into that theme category. Factor scores were developed 
by adding together the scores on each item, and dividing by the total number of items in 
that category.  After establishing these factor scores, they were correlated with other 
variables such as motivation for treatment (i.e., the Readiness scale on the URICA), age, 
psychological distress, as well as severity in the medical, drug, alcohol, and family/social 
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realms in order to determine whether certain factors have stronger associations with other 
variables.  
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Results 
Demographic variables 
Of the 51 individuals entering into this study, 41 (80.4%) were male, 10 (19.6%) 
were female, and 31 (60.8%) were Caucasian. Most participants (90.2%) reported their 
sexual orientation as heterosexual. The mean age of the participants was 32.3 years 
(range = 19– 57 years old, SD = 10.1). On average, participants reported completing 12.3 
years (SD = 2.2) of education. These demographic variables are shown on Table 1. 
Psychosocial stability 
Findings on family relationships, family abuse history, employment, and legal 
history are shown in Table 2. One of the most notable results in this domain is the overall 
high rate of reported emotional, physical, and sexual abuse.  For the total sample, 54.9% 
reported emotional abuse in their lifetimes, 33.3% reported past physical abuse, and 
13.7% reported past sexual abuse. Also, the 35.5% of the sample had parents with a 
history of drug or alcohol use. 
The sample exhibited little stability in terms of employment and financial status.  
Specifically, 16% of participants reported receiving money from illegal sources within 
the 30 days prior to the interview. Participants reported income received from various 
sources within the 30 days prior to an interview (or prior to incarceration if the 
participant had been incarcerated over one month). The mean monthly net income for 
participants was $960.00 (SD = $1220).  Forty-five percent of participants reported 
having full-time employment at some point during the last three years. 
 To compare whether the BSI scores obtained for the current sample differed from 
those of three normative samples (adult non-patients, psychiatric outpatients, and 
psychiatric inpatients) provided by Derogatis (1992), two-tailed t-tests were calculated. 
   
 
48 
 
Table 3 provides means and standard deviations and Table 4 provides t-test results. 
Significant differences (p < .01) were revealed between the current sample and the 
normative non-patients on all but one subscale (Hostility). On all comparisons, the 
current sample of individuals provided more pathological symptom ratings than the adult 
non-patient comparison group. The psychiatric samples (both out- and inpatient) had 
significantly higher ratings than the current sample, except for the Somatic subscale, on 
which there were no significant differences between groups. We also examined BSI GSI 
scale in terms of motivation for treatment in our analyses, and these results are presented 
below.  
The total sample’s mean score on the BDI-II was 17.6 (SD = 11.5); scores ranged 
from 1-57. Note that this score is only out of 20 possible questions, as we removed the 
question on this instrument addressing suicidal ideation. Therefore, we multiplied our 
scores by the factor of 21/20 (1.05) to scale the scores to the normative data. Using the 
scaled data, we obtained a mean score of 18.6 (SD = 12.1). Using standard BDI-II cut-off 
scores, 21.6% of participants fell into the non-depressed category (scores between 0 and 
9), 45.0% were categorized as mild to moderately depressed (scores between 10 and 19), 
15.9% fell in the moderate to severe range of depression (scores between 19 and 29), and 
17.7% of the sample had scores in the severe depression range (scores between 30 and 
63).  
As was expected, participants reported extensive legal histories.  On average, 
individuals in our study spent 22.5 months of their lives incarcerated (SD = 25.9) with an 
average of 7.6 (SD = 12.3) convictions in their lifetimes, ranging from zero to 79. In 
terms of types of charges participants had accrued in their lifetimes, there was an 
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unsurprisingly high percentage of alcohol- and drug-related charges (note that we 
recruited individuals that had been recently arrested on a drug or alcohol charge, so this 
was a unique subset of the individuals at Missoula County Detention Facility). Sixty 
percent of participants had had at least one DUI, while 68.6% of participants reported 
having at least one drug charge (e.g., criminal possession of dangerous drugs, criminal 
possession of drug paraphernalia, criminal possession with intent to distribute).  
Motivation for treatment 
Overall, the mean Readiness score for the sample was 9.48 (SD = 2.43). 
According to the definition of DiClemente et al. (2004), this score indicates that the 
group, as a whole, was in the Contemplation stage of change with respect to substance 
use behavior. In terms of categorizing participants into stage of change groups, 15.7% of 
the sample fell in the Precontemplation group, 74.5% in the Contemplation group, and 
7.8% in the Preparation/Action stage of change.  
We computed bivariate correlations with demographic variables (age, gender, 
race, and education), motivation variables (stage of change scales and Readiness score), 
and the predictor variables for the proposed regression analysis (BSI Global Severity 
Index, ASI composite scores in the medical, alcohol, drug, and family/social sections). 
Table 5 presents the correlation matrix of the aforementioned variables. The results of 
each specific hypothesis related to motivation are described below. 
Hypothesis 1. We conducted a multiple regression analysis to determine whether 
the predictor variables (BSI Global Severity Index, ASI composite scores in the medical, 
alcohol, drug, and family/social sections) accounted for a significant proportion of the 
variance in the dependent variable (Readiness score). Demographic factors (age, gender, 
race, and years of education) were not significantly associated with the Readiness score 
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and therefore were not included in the model. After entering all independent variables 
into a multiple regression analysis, results indicated that the final model did not account 
for a significant amount of variance in the Readiness score (p= .067). Table 6 presents the 
results of the multivariate linear regression. Although the model itself was not 
significant, and Hypothesis 1 was not supported, individual variables appear to 
significantly predict motivation for change, substantiating other hypotheses proposed by 
the investigators.  
Hypothesis 2. To obtain more detail about how psychological functioning and 
motivation for treatment are related, we explored the data in two ways. First, we 
examined the correlation between the Readiness score and the BSI GSI, and then we 
determined if BSI subscale scores differed between stage of change groups. We found a 
significant correlation between the Readiness scores and GSI scores (r = .327, p < .05). 
For the next set of analyses, we conducted a series of one-way ANOVAs, using each BSI 
subscale score as an independent variable; the dependent variable was stage of change 
group (Precontemplation, Contemplation, Preparation/Action). Table 7 presents the 
results from these findings. There were significant differences between groups on each of 
the following BSI subscales: Somatization (F(2, 47) = 4.12, p = 0.022), Obsessive-
Compulsive (F(2, 47) = 4.32, p = 0.019), Psychoticism (F(2, 47) = 3.70, p = 0.032), and 
the GSI (F(2, 47) = 3.38, p = 0.043). Post hoc comparisons using the Tukey honestly 
significant difference (HSD) test indicated that the Precontemplation group had 
significantly lower scores than the Action/Preparation groups on the above mentioned 
scales. Those in the Precontemplation group also had significantly lower scores on the 
Obsessive-Compulsive scale than those in the Contemplation group. Taken together, 
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these results suggest that Hypothesis 2 was supported. That is, for our sample, level of 
motivation was related to psychological symptomatology, such that individuals in the 
Precontemplation stage of change exhibited less symptoms than those in the 
Action/Preparation group in the areas of somatization, obsessive compulsive tendencies, 
psychotism, as well the BSI’s overall measure of distress.  
Hypothesis 3.  Results indicated no significant relationship between motivation to 
change (the Readiness score) and the variable representing physical problems (the ASI 
composite scores on the Medical section). Specifically, the correlation between these 
variables was non-significant (r = .026, p = .872), and Hypothesis 3 was not supported. 
Hypothesis 4. Another variable we proposed as related to motivation was primary 
drug of abuse. We designated inclusion in each substance category based on data from 
the ASI into the following groups: no problem substance (self-reported; 7.8%), alcohol 
(41.2%), opiates (7.8%), methamphetamine (21.6%), marijuana/hallucinogens (7.8%), 
and polysubstance abuser (no primary substance identified; 13.7%). A one-way analysis 
of variance indicated a significant effect of drug of choice on participant motivation, as 
measured by the Readiness score (F  (5, 44) = 7.047, p < 0.001). We hypothesized that 
individuals who primarily used drugs with a higher addiction potential (e.g., opiates and 
alcohol) would report higher levels of motivation to change, and even though the 
ANOVA was significant, our hypothesis was not supported. Specifically, Tukey’s post-
hoc comparisons demonstrated that only one group (“no problem”) differed significantly 
from all other groups in terms of readiness to change. Specifically, the “no problem” 
group’s mean Readiness score was much lower (4.31; SD = 4.70) than the other groups.  
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We wanted to examine whether the “no problem” subgroup had erroneously been 
recruited into the sample. We took a closer look at the make up of this group in terms of 
substance use history, as well as the charges for which they had been incarcerated at the 
time of recruitment. Of the four participants within this group, three reported at least two 
days of substance use the 30 days prior to the interview.  One individual had consumed 
alcohol 12 days out of the past 30, and also reported an eleven year history of regular 
alcohol use, a one year history of using heroin, other opiates, and methamphetamine, a 
three year history of regular cocaine use, and a 14 year history of regular marijuana use. 
Another person reported using alcohol on one out of the past 30 days prior to the 
interview; this participant also reported a one year history of using both opiates and 
sedatives on a regular basis. A third member of this group reported using 
methamphetamine (four days) and marijuana (three days) out of the past 30. This person 
also reported a one year history of regular alcohol use, a three year history of 
methamphetamine use, and a four year history of marijuana use. The participant who 
reported no substance use in the past 30 days had a one year history of regular marijuana 
use.  
Hypothesis 5. We used the ASI composite scores for the Alcohol and Drug 
sections as proxy variables representing duration of addiction, as years of substance use is 
one variable comprising these scores. We found that neither of the Alcohol and Drug 
composite scores were significantly related to motivation for treatment, as measured by 
the Readiness scores (r = 2.603, p = .113; r = .481, p = .491 respectively). Therefore, 
our prediction that duration of addiction would be positively correlated with motivation 
for treatment was not supported by the data. 
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Hypothesis 6.  Consistent with our stated hypothesis, motivation for treatment and 
distress in family/social relationships were related in our sample. In fact, when we 
examined each individual variable’s impact on the dependent variable, we found that the 
strongest predictor of motivation was the amount of family/social distress (measured by 
the ASI Family/Social composite score; r = 9.121, p = .004). Specifically, this 
relationship indicated that the higher degree of family/social distress, the more motivation 
for treatment participants reported. It should be noted that we discovered a positive 
correlation between GSI and the ASI family/social composite score, such that higher 
rates of psychological distress were related to higher rates of family/social discord (r = 
.602, p < .001).  
Hypothesis 7. When we compared differences in level of motivation between 
individuals choosing abstinence-based versus harm reduction treatment, we found 
support for our hypothesis that individuals choosing abstinence-based treatments reported 
more motivation for treatment. An independent samples t-test showed that the group who 
preferred abstinence-based treatment had higher Readiness scores (M = 10.35, SD = 
1.62) compared to those who chose harm reduction (M = 8.47, SD = 2.83; t(48) = 2.93, p 
= .005). Perhaps unsurprisingly, mean scores on the Readiness scale were significantly 
lower for the group that chose no treatment than for those who opted for their treatment 
of choice (M = 7.97, SD = 2.90 and M = 9.82, SD = 2.22 respectively; t(48) = 2.14, p = 
.038).  
Overall, 47.1% of the sample indicated they would prefer a harm reduction based 
treatment, while 52.9% preferred an abstinence based treatment. Treatment preference 
did not differ significantly by age or gender.  When asked to choose between attending 
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the treatment of their choice or no treatment at all, 80.4% indicated they would prefer to 
attend the treatment of their choice. A Pearson’s chi-square was calculated to determine 
whether the proportion of those who chose no treatment was higher in one treatment 
choice group or another. This procedure demonstrated that choosing treatment versus no 
treatment was significantly related to treatment preference, such that a higher proportion 
of individuals who preferred harm reduction also chose no treatment (χ2 = 9.207, p = 
.002).  
Exploratory analyses: Barriers to treatment 
Barriers to treatment endorsed by more than half the sample on the Barriers 
Questionnaire included the following: “My drug/alcohol use seemed fairly normal to me” 
(56.9%), “I thought I could handle it on my own” (70.6%), “I didn’t want to be told to 
stop using drugs/alcohol” (56.9%), “I didn’t want somebody telling me what to do with 
my life” (56.9%), “I liked drugs/alcohol and didn’t want to give them/it up” (60.8%) “I 
liked getting high/drunk” (68.6%), and “Using drugs/alcohol was a way of life for me” 
(56.9%). Barriers that were reported to have the least importance for participants are as 
follows (noted by the percentage of people who endorsed this item): “Someone important 
to me disapproved of my getting help” (9.8%), Somebody I know had a bad experience 
with treatment” (5.9%), “I was afraid of the people I might see” (7.8%), “Other people 
discouraged me from seeking help” (2.0%), and “I thought people would make fun of 
me” (5.9%).  
Table 8 shows each item on the Barriers Questionnaire, the percentage of the 
sample positively endorsing each item, and the factor in which the item was categorized. 
When items from the Barriers Questionnaire were grouped into our predetermined 
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factors, the lack of motivation category showed the highest average score (M = 1.41, SD 
= 0.75), followed by self-perception (M = 1.30, SD = 0.78), then negative perception of 
treatment (M = 0.79, SD = 0.50), cost/availability (M = 0.75, SD = 0.62), fear of 
consequences (M = 0.67, SD = 0.60), and lastly, stigma (M = 0.59, SD = 0.57). These 
scores did not significantly differ by gender, and they did not correlate with age.  
 We examined correlations between the scores in each category scores and other 
variables including the Readiness score, the BSI GSI, as well as the ASI composite scores 
from the medical, alcohol, drug, and family/social sections. Interestingly, the Readiness 
score and the score within the lack of motivation category derived from the Barriers 
Questionnaire were not related (r = .109, p = .451). Intuitively, these two constructs 
should correlate, most likely in a negative way such that higher scores on the lack of 
motivation scale on the Barriers Questionnaire would predict lower Readiness scores on 
the URICA. We address reasons for this mismatch in our discussion. Significant positive 
correlations were found between the GSI and three of the Barriers Questionnaire 
categories: cost/availability (r = .304, p = .030), negative perceptions of the treatment 
experience (r = .400, p = .004), and fear of outside consequences (r = .373, p = .007). 
The drug composite score was positively correlated to the fear of negative consequences 
factor (r = .318, p = .023).  
Exploratory analyses: Etiology of addiction 
One focus of this study to examine the pathways through which individuals 
developed substance abuse or dependence problems.  To this aim, people were asked to 
recall the age at which they began using substances.  For the entire sample, the mean age 
of first use of any substance was 12.3 (SD = 3.8).  Additionally, participants were asked 
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to discuss their primary problem substance and determine the age at which they felt their 
abuse of this substance became “problematic”.  The mean age at which problematic 
substance use began was reported to be 21.6 (SD = 6.8).  
In terms of how people were introduced to the first substance they ever used, 
43.5% indicated they were with a family member during the initial use of the first 
substance they ever used, and 30.4% of the sample reported that they were with a “close 
friend” the first time they used the problem substance. In response to this same item, 
about 13% reported being with a group of friends, 8.7% reported being alone , and 4.3% 
reported being with a “group of people whom I didn’t know.”  
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Discussion 
This study contributes to the knowledge base regarding motivation for treatment 
among non-treatment seeking substance abusers. To accomplish this aim, the 
investigators examined the construct of motivation, several possible variables that relate 
to a person’s readiness to change, as well as what might prohibit an individual’s change 
process. One strength of this research study is that we captured this information in an 
authentic way, using a sample of individuals who had not voluntarily presented to 
treatment. As well, most participants met at least one criterion for a substance abuse 
disorder as dictated by the American Psychiatric Association’s diagnostic guidelines 
(DSM-IV-TR; 2000). Specifically, individuals in the current study had recurrent 
substance-related legal problems. 
Motivation: Summary and interpretation 
Our findings provide support for the idea that individuals suffering with substance 
abuse disorders show some degree of readiness for change, and this level of motivation 
differs according to various aspects of a person’s psychosocial well being. Even though 
this sample was not seeking treatment, the results from the URICA indicate a relatively 
high level of readiness for change. Specifically, nearly three quarters of the sample 
reported being in a Contemplative stage of change in terms of substance use behaviors. 
These results suggest that study participants may have been contemplating behavior 
change, but did not do so because of certain barriers. An alternative interpretation would 
suggest that individuals in our sample were not motivated for treatment until incarcerated 
and subsequently recruited into the study, at which time they became more contemplative 
about change. Either way, our findings suggest that controlled settings represent a context 
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in which individuals may be open to the idea of treatment, or at least they may be willing 
to contemplate the consequences of substance use.  
In addition to looking at the URICA’s measure of intrinsic motivation, we also 
examined the variables that represent external motivators and how they affect readiness 
to change substance abuse behavior (i.e., the Readiness score). Although, as a whole, the 
suggested predictor variables did not predict readiness to change, several important 
individual relationships were present in the data. As predicted, psychological distress was 
related to motivation in our sample, such that increased levels of reported psychological 
symptomatology were found to be related to higher levels of motivation to change 
substance use behavior. This result might mean that psychological distress serves as 
motivating factor to change substance abuse behavior. Outreach and intervention, 
therefore, may look different for individuals suffering with more severe psychopathology. 
We talk about the practical application of this information below. Besides the apparent 
relationship between psychological distress and readiness to change, overall BSI and BDI 
scores demonstrate some degree of psychopathology in our sample. The prevalence of 
co-occurring psychological and substance abuse disorders is well documented in the 
literature, and consequently, this result is unsurprising.  
In addition to psychological distress, problems in the family/social sphere were 
associated with higher Readiness Scale scores in our sample. This indicates that those 
experiencing greater interpersonal problems are more likely to be motivated to change 
substance abuse behavior. These results highlight the importance of family and social 
relationships in influencing behavior, and they also illustrate the idea that family 
members not only influence the development and maintenance of substance abuse, but 
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also play a role in successfully intervening and helping an individual achieve abstinence.  
This kind of recognition has implications for involving families in treatment (discussed in 
more detail below). As with our results, other data indicate that family discord can be a 
motivator for treatment, sometimes in the form of informal mandates (e.g., ultimatums, 
threats; Gerdner & Holmberg, 2000; Polcin & Weisner, 1999).  
Interestingly, the other variables we hypothesized as being related to readiness to 
change (i.e., medical problems, duration of alcohol and drug use, and drug of choice) 
were not correlated to readiness to change in our sample. These variables were unrelated 
to motivation for change in our sample, and this may be one reason our overall regression 
model was not significant (another major reason for this finding may have been the small 
sample size resulting in lack of power). However, it is useful to consider why these 
individual variables were unrelated to the dependent variable in the first place. We will 
consider each of these nonsignificant relationships individually. Why would increased 
medical problems be unrelated to motivation for behavior change? This result is counter 
to one study (O’Toole, Pollini, Ford, & Bigelow, 2008), which found that 80% of 
substance abusers reported physical problems as a motivator for treatment. One possible 
reason for our finding could be directly related to the participant pool, a group of 
individuals with a mean age of 32.4 who are physically healthy enough to engage in 
criminal activity. Perhaps the current sample is more able bodied and therefore less 
responsive to the external motivator of health concerns. This logic would be in line with 
other research conducted by Marshall and Hser (2002). These researchers found that a 
group of substance abusers mandated to treatment from the criminal justice system had 
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better physical health status than the group who presented to treatment without legal 
mandates.  
Duration of addiction is another variable that was found to be unrelated to 
motivation for substance use behavior change, which is counter to the original 
hypothesis. The investigators hypothesized that the longer a person had been abusing 
substances, the more negative effects the person may have experienced from drug use, 
corresponding to more urgency to change. There could be several reasons why a 
statistically significant correlation between motivation and duration of addiction was not 
obtained, and we discuss one possibility here. One correlate of duration of addiction is 
number of treatment episodes, implying at least the same number of relapses. The 
individuals in our sample with lengthy substance abuse histories may have had low levels 
of self-efficacy around behavior change because of their many treatment or quit attempts, 
followed by a relapse. Several studies have linked self-efficacy and outcome expectations 
to the prediction of relapse for clients who present for treatment for both drinking 
behavior (McKay, Maisto, & O’Farrell, 1993; Rist & Watzl, 1983, Rychtarik, Prue, 
Rapp, & King, 1992; Sitharthan & Kavanagh, 1991), and drug use behaviors (Burling, 
Reilly, Moltzen, & Ziff, 1989). Using this logic, we might not have detected a 
relationship between motivation and duration of addiction because individuals in our 
sample with long-term addiction may have had low self-efficacy due to multiple 
treatment attempts, as well as low motivation for behavior change.  
 The final variable that we erroneously predicted would be related to readiness to 
change was that of drug of choice. We hypothesized incorrectly that individuals who 
abused drugs with a higher addiction potential (e.g., opiates) would show higher levels of 
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motivation to change than those who used, say, marijuana, a drug on which individuals 
typically do not experience severe physical withdrawal symptoms. It is possible that our 
results were influenced by the inherent difficulties in designating a “drug of choice.”  We 
based the variable representing primary drug of choice on the ASI question, which states: 
“Which substance is the major problem?” (referring to a list of drugs that the interviewer 
inquires about, both in terms of frequency as well as duration of use).  
Identifying a primary substance of abuse may be difficult, given that 
polysubstance abuse is so common among substance abuse treatment seekers; estimates 
indicate that prevalence of polysubstance abuse is around 50% (SAMHSA, 2006; Kedia, 
Sell, & Relyea, 2007). Deciding on one particular substance of abuse may be problematic 
because this process is highly subjective and may not reflect more objective measures 
such as frequency or length of addiction. Although the current participants could choose 
the option “more than one drug,” this category is named as such and does not specify 
particular substances or combinations of drugs. Thus, this category treats all 
polysubstance abuse as equal, and potentially important information may be lost. In the 
process of the analyses examining drug of choice and motivation, we found that 
individuals who chose “no substance” had the lowest level of readiness to change. This 
finding seems intuitive, as individuals not perceiving the substance use as being 
problematic will not see any need to change drug use behavior.  
Treatment Choice 
Two main findings from the treatment choice questionnaire provide important and 
applicable information for the field of substance abuse treatment. First, a higher 
percentage of participants chose an abstinence-based treatment rather than a harm-
   
 
62 
 
reduction philosophy of treatment. Second, individuals who chose the abstinence-based 
treatment option had higher levels of motivation than the harm reduction group. We 
consider these findings in order below.  
The current study’s script describing an abstinence-based philosophy of treatment 
was adopted from the language of traditional 12-Step oriented mutual support programs. 
These groups include Alcoholics Anonymous (AA), Narcotics Anonymous (NA), 
Cocaine Anonymous (CA), Crystal Meth Anonymous (CMA) and a number of others. 
Because of the similarity in language between our script and 12-Step programs, we could 
extrapolate that the current participants who preferred the abstinence-based treatment 
would be open to attending 12-Step meetings. Additionally, the group preferring the 
abstinence-based treatment would presumably be open to formal treatment programs that 
emphasize the 12 Steps. An alternative interpretation is that more participants preferred 
the abstinence-based treatment option because it sounded comparable to treatments they 
had already experienced, and therefore they felt the most comfortable with this option. In 
either case, the result is a positive one for the treatment community. This choice (i.e., 
treatment focusing on the12-Steps) represents an important, readily available, and 
pervasive resource in recovery from substance use disorders, whether associated with 
formal treatment or not  (Humphreys 1999; Kelly 2003). Furthermore, these mutual 
support programs are highly accessible and are available at no cost in communities 
throughout the world. For some individuals with substance use disorders, 12-Step 
programs are the only resource ever used to recover from an alcohol or drug problem 
(Hasin & Grant 1995; Kaskutas, Weisner, & Caetano, 1997). With uncertainty about state 
and federal budgets in the years to come, no-cost accessible support may be the best 
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alternative for many individuals in need of substance abuse treatment. Our data indicated 
that a higher percentage of the sample preferred this type of treatment, which assures that 
this population has at least one option for support and/or aftercare following a formal 
treatment episode.  
In line with our hypothesis, individuals who chose a 12-Step philosophy of 
treatment (as opposed to one along the lines of harm reduction) had higher levels of 
readiness to change substance use behavior. In fact, when asked the question of why the 
preferred treatment was chosen, individuals who chose 12-Step described the harm 
reduction treatment as one reserved for individuals with low levels of motivation. For 
example, one participant stated that “[harm reduction] sounds like a cop-out,” (39-year-
old male). Another participant indicated, “I'd rather go to [harm reduction treatment] 
because it was fun, but [abstinence-only] is the only way to get better” (35-year-old 
male). While the criticisms of harm reduction put forth by these participants may seem 
harsh, our results indicated that the group preferring harm reduction exemplified lower 
levels of motivation. According to the qualitative comments, the harm reduction group 
indicated their preference based on a genuine desire to experience a different type of 
treatment than 12-Step, something many people who chose harm reduction had already 
tried. One participant who preferred harm reduction stated, “[Abstinence-based 
treatment] is like ones I've done before and it hasn't worked” (47-year-old male). Another 
participant referred to the eighth step in the 12-Steps, which directs recovering 
addicts/alcoholics to make a list of all persons harmed over the course of an individual’s 
addiction, and make amends to them (Alcoholics Anonymous, 1981). This 52-year-old 
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male participant stated: “I don't want to apologize to nobody. It would put me in a 
situation where I'd want to go use.”  
Participants in both groups had strong feelings about the disease model of 
addiction. Those who chose the abstinence-based model tended to agree with the disease 
model concept, epitomized by a 21-year-old male who explained why he preferred this 
model by stating: “Because I believe that my addiction is definitely a disease. Someone 
telling me where to get clean needles isn’t going to help me. Once I start, I can’t stop. 
There’s no in between for me.” Alternatively, a different participant with the same 
identifying information (21-year-old male) preferred harm reduction and did not accept 
the disease model, he stated: “I don’t think it’s a disease. I think a lot of it is influenced 
by your environment.” Another participant explained: “I don’t consider drug addiction to 
be a disease. I’ve seen several people to go NA and AA and it hasn’t worked for them” 
(35-year-old male). This comment also demonstrates the participant’s opinions about the 
ineffectiveness of 12-Step programs, though in this case his outlook was gained 
vicariously.  
Barriers to treatment 
Consistent with the findings of Miller, Sovereign and Krege (1988) who 
examined problem drinkers, the barriers endorsed by more than half of the current sample 
had to do primarily with motivation and self-perception of drug use. Although motivation 
was cited as a barrier to treatment, the majority of the sample reported contemplating 
change according to the URICA, indicating some level of motivation. The results may 
seem opposing; however, one can interpret these findings as the sample’s exhibition of 
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ambivalence about change, a common characteristic of many people contemplating 
behavior change. 
Interestingly, the barriers that participants tended to select were self-imposed in 
nature, as opposed to systemic. This means that the sample’s perception is that substance 
abuse treatment is available, as long as the individual is ready enough to change. In many 
ways, the systemic barriers (e.g., lack of transportation or funding for treatment) seem 
easier to break down, given that jurisdictions have appropriate funding. But how do we 
address this other type of barrier, one that is marked by a person’s ambivalence about 
change or self-identified role as a substance abuser? Because we know that motivational 
interventions (i.e., motivational interviewing, motivational enhancement therapy) help 
individuals resolve ambivalence about problematic behavior, this direction would seem 
appropriate for the population of non-treatment seeking substance abusers. Next we 
consider implementation issues of such an intervention and other implications of our 
research findings. 
Future directions for researchers and clinicians 
Researchers, clinicians, and policy makers alike can utilize, as well as build 
upon, our findings. We suggest that the aforementioned professionals reflect on the 
finding that the majority of our participants reported contemplating behavior change. It 
would be easy to assume that substance abusing inmates or other non-treatment seeking 
chronic substance abusers are not interested in treatment, but our results suggest 
differently. Instead, our findings imply that non-treatment seekers are contemplating 
behavior change, which illustrates a need to develop programs that would be directed 
toward this group and capitalize on their existing motivation. Such programs could take 
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the form of brief motivation enhancing interventions implemented in detention facilities 
and prisons, targeting a population similar to the one used in the current sample. 
Additionally, these efforts could take place in other controlled environments where 
non-treatment seeking substance abusers may gather, including detoxification facilities 
and medical settings.  
We also have information about how interventions and outreach could be catered 
to certain substance abusing groups. Based on our results, for example, we might 
recommend that an emphasis on physical problems as a motivational factor be used in 
health care settings, but not in detention facilities. Our result showing a seeming lack of 
connection between duration of addiction and readiness to change may be useful for 
providers implementing brief motivational techniques, as this information indicates that 
all individuals may benefit from such interventions, not just ones who have exemplified 
long-term addictions.  
Going a step further, we can use our data to help funnel individuals into an 
appropriate type of treatment, one that might fit with their particular preference. Although 
past treatment matching studies have not shown favorable outcomes when assigning 
particular patients characteristics with specific treatments, our results indicate that more 
motivated individuals may be better suited for 12-Step oriented treatments. Conversely, 
people exemplifying lower levels of motivation would appear to be well matched to a 
treatment emphasizing harm reduction. At the very least, it seems logical to match 
individuals who prefer 12-Step treatment to a treatment focusing on “working the steps” 
and attending meetings. A different approach to treatment could be suggested for those 
opposed to the 12-Step philosophy, perhaps one that focused on a biopsychosocial model 
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of addiction (as opposed to a disease model). Also, an alternative to 12-Step based 
treatment might use interventions targeting all stages of change rather than just 
Contemplation or Action. 
Our finding indicating a positive correlation between readiness to change and 
psychological distress has implications for developing intervention and outreach 
programs that target groups struggling with psychological problems. One such program is 
described by Magura, Cleland, Vogel, Knight, and Laudel (2007): the Double Trouble in 
Recovery (DTR), a specialized 12-Step program for individuals suffering with comorbid 
psychiatric and substance abuse problems. These researchers found that this program was 
successful. Specifically, attendance and involvement with this treatment was significantly 
associated with Self-efficacy for Recovery and three quality of life measures: Leisure 
Time Activities, Feelings of Well-Being, and Social Relationships. DTR appears to be a 
promising example of available treatment that could be integrated into a comprehensive 
treatment for individuals with comorbid disorders.  
Another connection we made through our results is that between the importance 
of family discord and motivation for treatment, underscoring the need to integrate 
family into treatment or treatment referral for substance abusers. Although certain 
family therapies have been tested empirically, Whittinghill (2002) pointed out that 
many substance abuse treatment providers are woefully undertrained in family therapy 
techniques.  
While the issue of practicing within one’s competency is applicable to 
professionals treating any population, it may be especially relevant for the area of 
substance abuse. Whittinghill cited research that indicated 40-55% of substance abuse 
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services, including family therapy, “are provided by paraprofessional counselors who 
lack formal counselor preparation” (p. 76).  It is clear from these statistics that we have 
training needs in the substance abuse treatment field that have not been met. This has 
implications for providers who are using family therapy techniques with their substance 
abusing clients. For example, clinicians using family therapy who adhere to the family 
disease model of addiction (which is more common among paraprofessionals), may 
place family members in a victim role, focus on how families enable the user, and 
ignore other important familial issues. We are unsure about whether this kind of 
approach could be helpful (there is no empirical evidence suggesting that it is), but 
more worrisome is the idea that such treatment could actually be harmful to clients. It 
seems that such as approach would have to employed with a great deal of care, lest 
family members blame themselves for the addiction of their loved one, increasing their 
overall level of distress.  
Researchers should consider further investigation and development on 
treatments that include the entire family. Although there are examples of intervention 
strategies involving family members, there is really only one treatment supported by 
empirical evidence that directly involves family: Behavioral Couples Therapy (BCT; 
O’Farrell & Fals-Stewart, 2000). Nonetheless, this treatment just focuses on the couple, 
excluding other family members that may be affected.  
Perhaps even before a discussion of the development of new treatments that 
incorporate families, we might further the field of substance abuse treatment by 
figuring out how to integrate treatments into practice before developing new ones. 
According to research, the inclusion of family members in substance abuse treatment 
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can be beneficial. Ironically, what is occurring in current clinical practice does not 
mirror our empirical data. For example, there is a plethora of evidence supporting the 
efficacy of BCT; however, Fals-Stewart and Birchler (2000) found that a very small 
percentage of community-based outpatient treatment programs in the United States 
actually use BCT. On the other hand, we know that the use of mutual self-help groups 
enjoy widespread popularity. According to a national survey conducted by Room and 
Greenfield (1993), approximately 4.6% of the population has attended Al-Anon at some 
time in their lives. These same researchers estimated that 1.7% of the population has 
attended similar groups such as Adult Children of Alcoholics (ACA or ACOA). To 
summarize, we need to promote the use of evidenced-based family therapies in existing 
community-based treatment programs. Such programs serve the lion’s share of 
substance abusers, yet few of the family treatments are widely used in these settings. 
Study limitations and strengths 
This study has a number of methodological limitations.  First, the sample was 
small, and this limits the power to detect significant differences or association between 
the key variables.  Data collection for this study relied on self-report; a direct measure of 
substance use (such as urine screens) was not available for our sample.  Even so, research 
on self-report data with substance using populations has shown high reliability with 
biological markers of use (e.g. Sherman & Bigelow, 1992; Zanis, McLellan & Randall, 
1994).  On a related note, participants were asked to respond to items on the ASI 
regarding events in the past, for example the number of times they had been arrested.  
Such information may be subject to memory biases, and the accuracy of endorsement 
may be obscured by past or recent substance use.  
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As mentioned before, the primary strength of this study was its sample: non-
treatment seeking individuals who struggle with substance abuse issues. This study of 
non-treatment seeking users as they exist in rural areas, such as Montana, has served to 
widen the scope of available data on rural substance abuse and increase awareness about 
motivation within this group. Another strength of this study is that we included an 
abundance of measures used for the purposes of understanding the sample on multiple 
levels. In particular, looking at treatment choice is a unique variable to examine with this 
population. Our hope is to begin giving the treatment-receiving population a platform for 
stating their preference on issues that apply directly to them. Although many individuals 
receiving substance abuse treatment are in positions where choice has been eliminated, 
we feel strongly that the success of treatment might be informed by its consumers.  
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Appendix A. Etiology of addiction questionnaire.  
Etiology of Addiction Questionnaire 
 
Instructions: 
The following questions will ask you some questions about your past drug and alcohol 
use.  Please answer them to the best of your ability. 
 
F irst substance ever used 
Code Question text Answers 
id ID  
f_sub What was the first substance you 
used?  (You can check more than 
one.)  Note: Please do not include 
prescription drugs taken as 
prescribed.  
 
1 = Tobacco (cigarettes or chewing tobacco) 
2 = Alcohol  
3 = Marijuana 
4 = Inhalants (gas huffing, glue sniffing, etc.) 
5 = Hallucinogens  
6 = Methamphetamine 
7 = Cocaine 
8 = Opiates (heroin, oxycontin, etc.) 
9 = Other ____________________________ 
-8 = N/A 
-9 = Don’t know/no answer 
f_age How old were you at the time of 
your first [first substance] use?  
 
-8 = N/A 
-9 = Don’t know/no answer 
f_person Who were you with the first time 
you used [first substance]? Check 
all that apply. 
1 = A close friend  
2 = A group of close friends 
3 = An acquaintance whom I didn’t know 
well 
4 = A group of people whom I didn’t know 
well 
5 = Family members  
6 = Other  
7 = Alone 
-8 = N/A 
-9 = Don’t know/no answer 
f_obtain Who obtained the substance the 
first time you used it?  
1 = A close friend  
2 = A group of close friends 
3 = An acquaintance whom I didn’t know 
well 
4 = A group of people whom I didn’t know 
well 
5 = Family members 
6 = Other  
7 = Alone 
-8 = N/A 
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-9 = Don’t know/no answer 
f_rate How would you rate your first 
experience with [first substance]?   
1 = Very positive 
2 = Somewhat positive  
3 = Fair 
4 = Somewhat negative 
5 = Very negative 
-8 = N/A 
-9 = Don’t know/no answer 
f_expect What did you expect to happen, 
and how did you expect to feel?  
 
-8 = N/A 
-9 = Don’t know/no answer 
Second substance ever used 
s_sub What was the second substance you 
used?  Note: Please do not include 
prescription drugs taken as 
prescribed. 
1 = Tobacco (cigarettes or chewing tobacco) 
2 = Alcohol  
3 = Marijuana 
4 = Inhalants (gas huffing, glue sniffing, etc.) 
5 = Hallucinogens  
6 = Methamphetamine 
7 = Cocaine 
8 = Opiates (heroin, oxycontin, etc.) 
9 = Other ____________________________ 
-8 = N/A 
-9 = Don’t know/no answer 
s_age How old were you at the time of 
your first [second substance] use?  
 
-8 = N/A 
-9 = Don’t know/no answer 
s_person Who were you with the first time 
you used [second substance]? 
1 = A close friend  
2 = A group of close friends 
3 = An acquaintance whom I didn’t know 
well 
4 = A group of people whom I didn’t know 
well 
5 = Family members 
brother 
6 = Other 
7 = Alone  
-8 = N/A 
-9 = Don’t know/no answer 
s_obtain Who obtained the substance the 
first time you used it?  
1 = A close friend  
2 = A group of close friends 
3 = An acquaintance whom I didn’t know 
well 
4 = A group of people whom I didn’t know 
well 
5 = Family members 
6 = Other 
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7 = Alone  
-8 = N/A 
-9 = Don’t know/no answer 
s_other Were you using other substances at 
the time you tried [second 
substance]? (Yes/No)  
0 = No 
1 = Yes 
-8 = N/A 
-9 = Don’t know/no answer 
s_othsub If yes, please list other substances. 1 = Tobacco (cigarettes or chewing tobacco) 
2 = Alcohol  
3 = Marijuana 
4 = Inhalants (gas huffing, glue sniffing, etc.) 
5 = Hallucinogens  
6 = Methamphetamine 
7 = Cocaine 
8 = Opiates (heroin, oxycontin, etc.) 
9 = Other ____________________________ 
-8 = N/A 
-9 = Don’t know/no answer 
s_rate How would you rate your first 
experience with [second 
substance]?   
1 = Very positive 
2 = Somewhat positive  
3 = Fair 
4 = Somewhat negative 
5 = Very negative 
-8 = N/A 
-9 = Don’t know/no answer 
s_expect What did you expect to happen, 
and how did you expect to feel?  
 
-8 = N/A 
-9 = Don’t know/no answer 
Third substance ever used 
t_sub What was the third substance you 
used?  Note: Please do not include 
prescription drugs taken as 
prescribed.  
1 = Tobacco (cigarettes or chewing tobacco) 
2 = Alcohol  
3 = Marijuana 
4 = Inhalants (gas huffing, glue sniffing, etc.) 
5 = Hallucinogens  
6 = Methamphetamine 
7 = Cocaine 
8 = Opiates (heroin, oxycontin, etc.) 
9 = Other ____________________________ 
-8 = N/A 
-9 = Don’t know/no answer 
t_age How old were you at the time of 
your first [third substance] use?  
 
-8 = N/A 
-9 = Don’t know/no answer 
t_person Who were you with the first time 
you used [third substance]?  
1 = A close friend  
2 = A group of close friends 
3 = An acquaintance whom I didn’t know 
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well 
4 = A group of people whom I didn’t know 
well 
5 = Family members 
6 = Other 
7 = Alone  
-8 = N/A 
-9 = Don’t know/no answer 
t_obtain Who obtained the substance the 
first time you used it?  
1 = A close friend  
2 = A group of close friends 
3 = An acquaintance whom I didn’t know 
well 
4 = A group of people whom I didn’t know 
well 
5 = Family members 
6 = Other 
7 = Alone  
-8 = N/A 
-9 = Don’t know/no answer 
t_other Were you using other substances at 
the time you tried [third 
substance]? 
0 = No 
1 = Yes 
-8 = N/A 
-9 = Don’t know/no answer 
t_othsub If yes, please list other substances. 1 = Tobacco (cigarettes or chewing tobacco) 
2 = Alcohol  
3 = Marijuana 
4 = Inhalants (gas huffing, glue sniffing, etc.) 
5 = Hallucinogens  
6 = Methamphetamine 
7 = Cocaine 
8 = Opiates (heroin, oxycontin, etc.) 
9 = Other ____________________________ 
-8 = N/A 
-9 = Don’t know/no answer 
t_rate How would you rate your first 
experience with [third substance]?   
1 = Very positive 
2 = Somewhat positive  
3 = Fair 
4 = Somewhat negative 
5 = Very negative 
-8 = N/A 
-9 = Don’t know/no answer 
t_expect What did you expect to happen, 
and how did you expect to feel?  
 
-8 = N/A 
-9 = Don’t know/no answer 
Primary problem substance(s) 
p_sub What do you consider to be your 1 = Tobacco (cigarettes or chewing tobacco) 
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primary problem substance(s)?   2 = Alcohol  
3 = Marijuana 
4 = Inhalants (gas huffing, glue sniffing, etc.) 
5 = Hallucinogens  
6 = Methamphetamine 
7 = Cocaine 
8 = Opiates (heroin, oxycontin, etc.) 
9 = Other ____________________________ 
-8 = N/A 
-9 = Don’t know/no answer 
p_age If you have not discussed this 
substance in the F irst, Second, or 
Third substance ever used, please 
answer the following question. 
How old were you at the time of 
your first [problem substance] use? 
 
-8 = N/A 
-9 = Don’t know/no answer 
 
age_prob At what age did you feel your use 
of [problem substance] became 
“problematic”?   
 
-8 = N/A 
-9 = Don’t know/no answer 
why_prob Describe in your own words why 
you think your substance use 
escalated to a problematic level. 
 
-8 = N/A 
-9 = Don’t know/no answer 
p_person If you have not discussed this 
substance in the F irst, Second, or 
Third substance ever used, please 
answer the following questions.  
Who were you with the first time 
you used [problem substance]? 
1 = A close friend  
2 = A group of close friends 
3 = An acquaintance whom I didn’t know 
well 
4 = A group of people whom I didn’t know 
well 
5 = Family members 
6 = Other 
7 = Alone  
-8 = N/A 
-9 = Don’t know/no answer 
p_other Were you using other substances at 
the time you tried [problem 
substance]? (Yes/No)   
0 = No 
1 = Yes 
-8 = N/A 
-9 = Don’t know/no answer 
p_othsub If yes, please list other substances. 1 = Tobacco (cigarettes or chewing tobacco) 
2 = Alcohol  
3 = Marijuana 
4 = Inhalants (gas huffing, glue sniffing, etc.) 
5 = Hallucinogens  
6 = Methamphetamine 
7 = Cocaine 
8 = Opiates (heroin, oxycontin, etc.) 
9 = Other ____________________________ 
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-8 = N/A 
-9 = Don’t know/no answer 
p_rate How would you rate your first 
experience with [problem 
substance]?   
1 = Very positive 
2 = Somewhat positive  
3 = Fair 
4 = Somewhat negative 
5 = Very negative 
-8 = N/A 
-9 = Don’t know/no answer 
why_use In your own words, why do you use 
drugs/alcohol?  
 
-8 = N/A 
-9 = Don’t know/no answer 
quit_pri Before now, have you ever tried to 
quit [problem substance]? 
(Yes/No) 
0 = No 
1 = Yes 
-8 = N/A 
-9 = Don’t know/no answer 
 If “Yes”, please answer the 
following 2 questions.  If “No”, 
please skip to the next question. 
 
quit_num How many times have you tried to 
quit?  
 
-8 = N/A 
-9 = Don’t know/no answer 
quittime What is the longest period of time 
you have been clean?  
 
-8 = N/A 
-9 = Don’t know/no answer 
quit_mot What was your motivation for 
quitting?  
 
-8 = N/A 
-9 = Don’t know/no answer 
quit_dif In your own words, what was the 
most difficult aspect of quitting?   
 
-8 = N/A 
-9 = Don’t know/no answer 
Psychological H ealth H istory 
The following questions have to do with your psychological health before you started using any drugs 
or alcohol. 
psyhltpr How would you describe your 
psychological health before you 
started using drugs or alcohol? 
1 = Very good 
2 = Somewhat good  
3 = Fair 
4 = Somewhat poor 
5 = Very poor 
-8 = N/A 
-9 = Don’t know/no answer 
psy_dxp Were you diagnosed with any 
psychological disorders before you 
began using substances 
(depression, ADHD, etc.)? 
(Yes/No)  
0 = No 
1 = Yes 
-8 = N/A 
-9 = Don’t know/no answer 
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psydxtyp If “Yes”, list diagnosis.   -8 = N/A 
-9 = Don’t know/no answer 
psy_undx Before you began using substances, 
do you believe you suffered from 
undiagnosed psychological 
disorders such as depression or 
ADHD? (Yes/No)  
0 = No 
1 = Yes 
-8 = N/A 
-9 = Don’t know/no answer 
psyundxt If “Yes”, list diagnosis.  
-8 = N/A 
-9 = Don’t know/no answer 
psy_trau Did you suffer from a traumatic 
event before you began using 
substances? 
0 = No 
1 = Yes 
-8 = N/A 
-9 = Don’t know/no answer 
 
psyhltcu How would you describe your 
psychological health now? 
1 = Very good 
2 = Somewhat good 
3 = Fair 
4 = Somewhat poor 
5 = Very poor 
-8 = N/A 
-9 = Don’t know/no answer 
psy_chng How do you feel your 
psychological health has changed 
since you started using substances? 
 
 
-8 = N/A 
-9 = Don’t know/no answer 
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Appendix B. Treatment choice rationales  
The following are descriptions of two types of substance abuse treatment: Treatment A 
and Treatment B. Please read each of them. Imagine that you are given a choice between 
these two treatments to help you with an addiction problem. You have to choose one of 
them. Please mark an “X” by the treatment you would rather have. Once you have 
finished, please go on to the next page for further instruction. Thank you! 
  
Treatment A ________  
 
With Treatment A, your counselor is a person who believes that addiction is a disease 
from which people can never be cured, but can work on recovery. In Treatment A, you 
will meet individually with a counselor to focus on staying 100% clean from all drugs 
and alcohol. You will also meet in a group setting in order to get support for being clean. 
In such groups, you might work through the 12-steps outlined by an Alcoholics 
Anonymous (AA) or Narcotics Anonymous (NA) program. Such steps include 
apologizing to people in your life that you may have hurt through your substance use. 
Individual and group sessions will occur once per week.  
 
Treatment A has a strict policy around drug use, and you will be randomly drug tested to 
determine if you have been using drugs. The purpose of this is to encourage you to stay 
clean. Positive urine screens will result in you getting kicked out of Treatment A.  
 
Treatment B________ 
With Treatment B, your counselor is a person who believes that addiction is not a 
disease, but is a process that is influenced by a person’s genetics, mindset, and 
environment. In Treatment B, you will meet individually with a counselor to help you 
reduce the harmful consequences of your drug or alcohol use. For example, you might 
identify problems are related to drug or alcohol use (like getting in a car accident because 
of drunk driving or getting a disease because of sharing needles). Then, you and your 
counselor would talk about a plan to (like finding a sober driver or where you would get 
clean needles) as a way to avoid the problems associated with drug and alcohol use. As a 
part of Treatment B, you will meet in a group setting as well. Here, you can talk to and 
get support from other people who are attempting to reduce the negative consequences 
related to drug and alcohol use. Individual and group sessions will occur once per week. 
Treatment B sees relapse as a learning experience, and if you use while in this treatment, 
you will work with your counselor to determine what can be learned from this 
experience. You will not get kicked out of treatment for using in Treatment B.  
Please continue on to the next page.
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F inal Choice 
Now, imagine that you have the choice between attending the treatment that you choose 
above, and no treatment at all. Please indicate what you would choose to do in this 
situation. Mark an “X” next to your choice. 
_______  I would choose to attend my  treatment of choice.  
_______  I would choose not to attend treatment at all. 
 
   
 
99 
 
Table 1  
 
Sample characteristics.   
 
  
Total Sample 
(N = 51) 
 
 
 
 
 
Race 
   
     
     Caucasian 
 
31 (60.8%) 
  
    
     African American 
     
     Native American 
3 (5.9%) 
 
12 (23.5%) 
  
 
     Hispanic 
 
5 (9.8%) 
  
 
Gender 
   
     
     Male 
 
41 (80.4%) 
  
     
     Female 
 
10 (19.6%) 
  
 
Mean age (SD) 
 
32.4 (10.1) 
  
 
Reported Sexual Orientation 
   
     
     Heterosexual 
 
46 (90.2%) 
  
     
     Gay  
 
2 (3.9%) 
  
     
     Lesbian 
 
0 
  
 
    Bisexual 
 
2 (3.9%) 
  
 
    Prefer not to answer 
 
1 (2.0%) 
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Table 2 
 
Psychosocial stability  
 
  
Total Sample 
(N=51) 
 
Emotionally abused in lifetime, % 
 
54.9 
 
Physically abused in lifetime, % 
 
33.3 
 
Sexually abused in lifetime, % 
 
13.7 
 
Participants reported that one or both parents 
had an alcohol or drug problem, % 
 
35.5 
 
  
Monthly net income, past 30 days (SD) $960 (1220) 
  
Reported receiving illegal income, past 30 days, 
% 
16 
  
Reported having full-time employment, past 3 
years, % 
45 
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Table 3 
 
Means and standard deviations of BSI subscale scores for current and normative samples 
 
______________________________________________________________________________________________________ 
 
    Current sample    Normative samples      
 
    Overall Female Male  Adult non- Psychiatric Psychiatric  
    (N=51) (N=10)  (N=40)  patient  outpatient inpatient 
          (N=719) (N=1002) (N=310) 
                  
 
    Mean    SD Mean    SD Mean    SD Mean    SD Mean    SD Mean    SD 
______________________________________________________________________________________________________ 
Somatization   .74 .95 .93 1.05 .69 .93 .29 .40 .83 .79 1.02 .91   
Obsessive-Compulsive 1.05 .96 1.01 1.16 1.04 .93 .43 .48 1.57 1.00 1.61 1.07 
Interpersonal Sensitivity .74 .90 .75 .75 .74 .94 .32 .48 1.58 1.05 1.48 1.11 
Depression   1.14 .97 1.30 .62 1.10 1.04 .28 .46 1.80 1.08 1.87 1.21 
Anxiety   .80 .88 .67 .83 .84 .90 .35 .45 1.70 1.00 1.70 1.16 
Hostility   .51 .69 .50 .59 .51 .71 .35 .42 1.16 .93 1.00 .97 
Phobic Anxiety  .41 .62 .30 .46 .43 .65 .17 .36 .86 .88 1.07 1.00 
Paranoid Ideation  .90 .79 1.02 .78 .87 .80 .34 .45 1.14 .95 1.26 1.23 
Psychoticism   .84 .78 1.00 .81 .80 .78 .15 .30 1.19 .87 1.27 .98 
GSI    .81 .71 .85 .56 .80 .75 .30 .31 1.32 .72 1.37 .86  
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Table 4 
 
t-test values for comparison between the current sample and normative samples for BSI subscales 
___________________________________________________________________________________________________ 
 
     Adult non-patient  Psychiatric outpatient  Psychiatric inpatient 
     (N=719)   (N=1002)   (N=310) 
___________________________________________________________________________________________________ 
Somatization    3.376**   -.688    -2.118 
Obsessive-Compulsive  4.557**   -3.880**   -4.176** 
Interpersonal Sensitivity  3.345*    -6.685**   -5.889** 
Depression    6.301**   -4.871**   -5.385** 
Anxiety    3.671**   -7.247**   -7.247**   
Hostility    1.625    -6.181**   -5.151** 
Phobic Anxiety   2.747*    -5.22**   -7.648** 
Paranoid Ideation   5.059**   -2.143    -3.223* 
Psychoticism    6.304**   -3.208*   -3.940** 
GSI     5.105**   -5.167**   -5.671**    
*p < .01 
**p < .001 
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Table 5 
 
Correlations among predictor and outcome variables 
*p < .05  **p < .01   
 
Variable 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
11 
 
12 
 
13 
 
14 
 
15 
 
1. Age 
 
- 
              
2. Gender 
3. Race 
4. Education 
-.288* 
-.265 
-.001 
- 
.432** 
.001 
 
- 
-.136 
 
 
- 
           
5. Precontemplation .061 -.120 -.046 -.283* -           
6. Contemplation 
7. Action 
8. Maintenance 
.058 
-.084 
.065 
.171 
.267 
.122 
.059 
.174 
.107 
.233 
-.116 
.180 
-.626* 
-.457* 
-.413* 
- 
.606** 
.685** 
 
- 
.625** 
 
 
- 
       
9. Readiness score 
10. BSI GSI 
-.004 
-.018 
.200 
.031 
.114 
-.051 
.192 
.036 
-.775* 
-.294* 
.885** 
.241 
.798** 
.246 
.830** 
.285* 
- 
.327* 
 
- 
     
11. Medical composite score 
12. Alcohol composite score 
.292* 
.008 
.034 
-.094 
.039 
-.034 
-.273 
.299* 
-.016 
-.213 
-.101 
.278* 
.024 
.035 
-.018 
.199 
-.023 
.227 
.071 
.097 
- 
.312** 
 
- 
   
13. Drug composite score 
14. Total years substance use 
15. Family/social composite 
score 
-.090 
.619* 
-.023 
.105 
-.143 
.052 
.127 
-.179 
.008 
-.007 
-.118 
.321* 
.079 
-.008 
-.359* 
.146 
.167 
.333* 
.155 
-.052 
.274 
.133 
.116 
.335* 
.100 
.075 
.400** 
.009 
-.008 
.603** 
.294** 
.243 
.019 
.307** 
.178 
.318** 
- 
-.037 
.187* 
 
- 
-.082 
 
 
- 
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Table 6 
 
Linear regression model predicting readiness to change. 
 
 
Predictors 
 
Regression 
coefficient 
 
SE 
 
t-Value 
 
p-value 
 
β 
 
 
Family/Social distress 
 
3.171 
 
2.076 
 
1.528 
 
.134 
 
.270 
     
Alcohol severity 
 
.498 .585 
 
1.173 .399 
 
.164 
 
Drug severity .124 .972 .765 .899 .103 
     
BSI Global Severity Index 
 
1.786 1.523 
 
.851 .247 
 
.147 
Medical severity 2.053 2.717 .127 .454 .018 
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Table 7 
 
Comparison of BSI scores for stage of change groups.  
 
BSI Subscales 
 
Group 
 
 
Mean 
score 
 
SD 
   
Somatization  
 
 
Total (N=51) 
 
 
0.63a 
 
 
0.82 
 
 
 
Obsessive-compulsive  
Precontemplation (n=8) 
Contemplation (n=38) 
Preparation/Action (n=4) 
0.09 
0.76a  
1.42a  
0.13 
0.12 
0.71 
   
      
Total (N=51) 
Precontemplation (n=8) 
Contemplation (n=38) 
Preparation/Action (n=4) 
 
1.06a 
0.23 
0.95a 
1.34a 
0.97 
0.08 
0.15 
0.67 
Interpersonal sensitivity  
     
 
 
Total (N=51) 
Precontemplation (n=8) 
Contemplation (n=38) 
Preparation/Action (n=4) 
 
0.76a 
0.22a 
0.94a 
0.97a 
 
0.90 
0.08 
0.15 
0.48 
 
Depression 
 
 
 
Total (N=51) 
Precontemplation (n=8) 
Contemplation (n=38) 
Preparation/Action (n=4) 
 
 
1.14a 
0.56a 
1.18a 
1.91a 
 
 
 
0.98 
0.65 
0.95 
1.34 
Anxiety 
 
 
Total (N=51) 
Precontemplation (n=8) 
Contemplation (n=38) 
Preparation/Action (n=4) 
 
0.81a 
0.46a 
0.81a 
1.40a 
 
0.89 
1.63 
0.86 
0.73 
 
Hostility 
 
 
 
Total (N=51) 
Precontemplation (n=8) 
Contemplation (n=38) 
Preparation/Action (n=4) 
 
 
0.52a 
0.38a 
0.55a 
0.45a 
 
 
0.69 
0.49 
0.74 
0.64 
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Phobic anxiety 
      
 
Total (N=51) 
Precontemplation (n=8) 
Contemplation (n=38) 
Preparation/Action (n=4) 
 
0.41a 
0.08a 
0.46a 
0.65a 
 
0.62 
0.10 
0.67 
0.60 
 
 
Paranoid ideation 
      
 
 
 
Total (N=51) 
Precontemplation (n=8) 
Contemplation (n=38) 
Preparation/Action (n=4) 
 
 
 
0.91a 
0.50a 
0.98a 
1.0a 
 
 
 
0.80 
0.43 
0.87 
0.33 
 
Psychoticism 
 
 
Total (N=51) 
Precontemplation (n=8) 
Contemplation (n=38) 
Preparation/Action (n=4) 
 
 
0.84a 
0.30a 
0.88a 
1.5 
 
 
0.90 
0.26 
0.76 
1.18 
 
Global severity index 
 
 
Total (N=51) 
Precontemplation (n=8) 
Contemplation (n=38) 
Preparation/Action (n=4) 
 
 
0.81a 
0.32 
0.86a 
0.99a 
 
 
0.72 
0.25 
0.71 
0.50 
 
Note. Any two means of the same BSI subscale score that share a common superscript are 
not significantly different. All other differences are significant at p < 0.05 by Tukey's 
post-hoc test. 
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Table 8 
Percentage endorsing items on the Barriers Questionnaire and corresponding factors 
Question % indicating 
“Important” or 
“Very Important” 
Factor 
1. My drinking/drug use seemed fairly normal to me.  56.9 Self-perception 
2. No one told me I had a problem with drugs/alcohol 
or encouraged me to seek help.  
25.5 Stigma 
3. I didn’t think I had a serious problem with 
drugs/alcohol. 
39.2 Self-perception 
4. I thought I could handle it on my own. 70.6 Self-perception 
5. I didn’t think of myself as an addict/alcoholic. 45.1 Self-perception 
6. I was concerned about what other people would 
think if me if I went for help. 
31.4 Stigma 
7. I was too embarrassed or ashamed. 37.3 Stigma 
8. I thought that my family would be embarrassed. 27.5 Stigma 
9. I thought my job might be in danger if I went for 
help. 
27.5 
 
Fear 
 
10. I didn’t know where to go for help. 23.5 Cost/Availability 
11. I didn’t want to be told to stop using drugs/alcohol. 56.9 Motivation 
12. I didn’t think it would do any good. 40.0 Negative perceptions  
13. I couldn’t afford to pay for help. 43.1 Cost/Availability 
14. I had no transportation, no way to get there. 19.6 Cost/Availability 
15. I needed someone to take care of my children 
while I was getting help. 
15.7 Cost/Availability 
16. I didn’t have the time. 35.3 Cost/Availability 
17. I was afraid I’d be put into a hospital. 15.7 Fear 
18. I didn’t think I needed any help. 41.2 Self-perception 
19. Someone important to me disapproved of my 
getting help. 
9.8 Stigma 
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20. I hate being asked personal question. 23.5 Negative perceptions  
21. I was afraid that I would fail, or that it wouldn’t 
help me. 
31.4 Fear 
22. I thought I was too young to be getting help or 
treatment. 
17.6 Self-perception 
23. I didn’t want somebody telling me what to do with 
my life. 
56.9 Negative perceptions  
24. I’ve had a bad experience with treatment before. 15.7 Negative perceptions  
25. Somebody I know had a bad experience with 
treatment. 
5.9 Negative perceptions  
26. I was afraid of what might happen in treatment. 19.6 Negative perceptions  
27. My drug/alcohol use wasn’t causing any problems 
as far as I could see. 
49.0 Self-perception 
28. I don’t like to talk in groups. 37.3 Negative perceptions  
29. I liked drugs/alcohol and didn’t want to give them 
up. 
60.8 Motivation 
30. I thought I’d lose my friends if I went for help. 13.7 Fear 
31. I was worried about the bad feelings of going 
through withdrawal from drugs/alcohol. 
13.7 Fear 
32. I didn’t know how I could live without 
drugs/alcohol. 
27.5 Self-perception 
33. I thought that going for help might get me in legal 
trouble. 
33.3 Fear 
34. It just seemed like too much trouble to go for help. 31.4 Motivation 
35. I liked getting high/drunk. 68.6 Motivation 
36. I couldn’t get time off from work. 17.6 Cost/Availability 
37. Using drugs/alcohol was a way of life for me. 56.9 Motivation 
38. Drugs/alcohol really had not caused much trouble 
or problems for me. 
37.3 Motivation  
39. I was afraid of the people I might see. 7.8 Negative perceptions 
40. Drugs/alcohol were/was not my main problem. 37.3 Self-perception 
41. I didn’t feel safe going where I’d have to go for 
help. 
13.7 Negative perceptions  
 
109 
 
42. There seemed to be more good than bad about 
drugs/alcohol for me. 
35.3 Motivation 
43. Other people discouraged me from seeking help. 2.0 Stigma 
44. I don’t like to talk about my personal life with 
other people. 
25.5 Negative perceptions  
45. I thought people would make fun of me. 5.9 Stigma 
46. I didn’t know what would happen to me. 19.6 Negative perceptions  
47. I didn’t want to go to AA, CA, NA, or other 
twelve-step groups. 
43.1 Negative perceptions  
48. I thought that “help” was for people who had 
worse problems than mine. 
43.1 Self-perception 
49. I had no insurance to pay for it. 23.5 Cost/Availability 
 
50. I thought my troubles would just go away without 
any help. 
41.2 Motivation 
 
 
 
